LogoPeqSERPE
logoCabeceraNinos

Hemos leído sobre ... Lupus

Última actualización: 22 mayo 2022
 
 
 
ABRIL 2022
  • Rodríguez-Lozano AL, Rivas-Larrauri FE, García-de la Puente S, Alcivar-Arteaga DA, González-Garay AG.
    Prognostic Factors at Diagnosis Associated With Damage Accrual in Childhood-Onset Systemic Lupus Erythematosus Patients.
    Front Pediatr. 2022 Apr 22;10:849947. doi: 10.3389/fped.2022.849947. eCollection 2022.
    https://pubmed.ncbi.nlm.nih.gov/35529331/

  • Gallagher KL, Patel P, Beresford MW, Smith EMD.
    What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?
    Front Pediatr. 2022 Apr 14;10:884634. doi: 10.3389/fped.2022.884634. eCollection 2022.
    https://pubmed.ncbi.nlm.nih.gov/35498799/

 
MARZO 2022
  • Zheng Z, Zhang H, Peng X, Zhang C, Xing C, Xu G, et al.
    Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis: A Randomized Clinical Trial.
    JAMA Netw Open. 2022 Mar 1;5(3):e224492. doi: 10.1001/jamanetworkopen.2022.4492
    https://pubmed.ncbi.nlm.nih.gov/35353167/

  • Curtiss P, Walker AM, Chong BF.
    A Systematic Review of the Progression of Cutaneous Lupus to Systemic Lupus Erythematosus.
    Front Immunol. 2022 Mar 11;13:866319. doi: 10.3389/fimmu.2022.866319. 
    https://pubmed.ncbi.nlm.nih.gov/35359921/

  • Danza A, Graña D, Soto E, Silveira G, Carlomagno A, Rebella M.
    Prednisone and long-term damage in systemic lupus erythematosus: Which is the threshold dose? A pilot study.
    Lupus. 2022 Mar 30:9612033221093485. doi: 10.1177/09612033221093485. 
    https://pubmed.ncbi.nlm.nih.gov/35354060/

  • Chia YL, Tummala R, Mai TH, Rouse T, Streicher K, White WI, Morand EF, Furie RA.
    The Relationship between Anifrolumab Pharmacokinetics, Pharmacodynamics, and Efficacy in Patients With Moderate to Severe Systemic Lupus Erythematosus.
    J Clin Pharmacol. 2022 Mar 30. doi: 10.1002/jcph.2054. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/35352835/

  • Parperis K, Kyriakou A, Voskarides K, Chatzittofis A.
    Suicidal behavior in patients with systematic lupus erythematosus: Systematic literature review and genetic linkage disequilibrium analysis.
    Semin Arthritis Rheum. 2022 Mar 19;54:151997. doi: 10.1016/j.semarthrit.2022.151997. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/35344734/

  • Olivieri G, Ceccarelli F, Perricone C, Ciccacci C, Pirone C, Natalucci F, Spinelli FR, Alessandri C, Borgiani P, Conti F.
    Fever in systemic lupus erythematosus: associated clinical features and genetic factors.
    Clin Exp Rheumatol. 2022 Mar 23. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/35349414/

  • Gu Z, Lu Q, Zhang A, Shuai ZW, Liao R.
    Analysis of Ocular Surface Characteristics and Incidence of Dry Eye Disease in Systemic Lupus Erythematosus Patients Without Secondary Sjogren's Syndrome.
    Front Med (Lausanne). 2022 Mar 7;9:833995. doi: 10.3389/fmed.2022.833995. 
    https://pubmed.ncbi.nlm.nih.gov/35355597/

  • Crawford LR, Neparidze N.
    Refractory autoimmune hemolytic anemia in a systemic lupus erythematosus patient: A clinical case report.
    Clin Case Rep. 2022 Mar 18;10(3):e05583. doi: 10.1002/ccr3.5583.
    https://pubmed.ncbi.nlm.nih.gov/35340637/

  • Chaoyi M, Shrestha B, Hui L, Qiujin D, Ping F.
    Tocilizumab therapy for persistent high-grade fever in systemic lupus erythematosus: two cases and a literature review. J Int Med Res. 2022 Mar;50(3):3000605221088558. doi: 10.1177/03000605221088558.
    https://pubmed.ncbi.nlm.nih.gov/35350923/

  • Sherman MA, Gunawardana A, Amirault JP, Moudgil A, Bost JE, Sule S, Srinivasalu H.
    Autoantibody cluster analysis in juvenile lupus nephritis.
    Clin Rheumatol. 2022 Mar 28. doi: 10.1007/s10067-022-06146-7. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/35347489/

  • Gezgin Yıldırım D, Bakkaloğlu SA.
    Monogenic lupus caused by mutations in DNASE1L3: A rare cause of systemic lupus erythematosus in children
    Scand J Immunol. 2022 Mar 18:e13162. doi: 10.1111/sji.13162. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/35302646/

  • Al-Mughales JA.
    Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters.
    Front Immunol. 2022 Mar 14;13:850759. doi: 10.3389/fimmu.2022.850759.
    https://pubmed.ncbi.nlm.nih.gov/35359932/

 
FEBRERO 2022
  • Cannon L, Wenderfer SE, Lewandowski LB, Cooper JC, Goilav B, Knight AM, Hersh AO, Ardoin SP, Sadun RE; CARRA Lupus Nephritis Workgroup.
    Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-onset Systemic Lupus Erythematosus in North America.
    J Rheumatol. 2022 Feb 15:jrheum.210428. doi: 10.3899/jrheum.210428. 
    https://pubmed.ncbi.nlm.nih.gov/35169053/

  • Lythgoe H, Smith EMD, Killeen OG, Murphy R, Pilkington C, Pain CE, Beresford MW.
    Prospective epidemiological study of juvenile-onset Systemic Lupus Erythematosus in the United Kingdom and Republic of Ireland.
    Rheumatology (Oxford). 2022 Feb 3:keac064. doi: 10.1093/rheumatology/keac064. 
    https://pubmed.ncbi.nlm.nih.gov/35134124/

  • Madison JA, Gockman K, Hoy C, Tambralli A, Zuo Y, Knight JS.
    Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series.
    Pediatr Rheumatol Online J. 2022 Feb 23;20(1):17. 
    https://pubmed.ncbi.nlm.nih.gov/35197077/

  • Morán-Álvarez P, Andreu-Suárez Á, Caballero-Mota L, Gassiot-Riu S, Berrueco-Moreno R, Calzada-Hernández J, Antón-López J, Vázquez-Díaz M, Boteanu A.
    Non-criteria manifestations in the presence of antiphospholipid antibodies in a paediatric cohort.
    Rheumatology (Oxford). 2022 Feb 8:keac070. doi: 10.1093/rheumatology/keac070. 
    https://pubmed.ncbi.nlm.nih.gov/35137009/

  • Schonenberg-Meinema D, Bergkamp SC, Nassar-Sheikh Rashid A, Gruppen MP, Middelkamp-Hup MA, Armbrust W, Dolman K, Hak AE, Hissink Muller PCE, van Onna M, Swart JF, Kuijpers TW, Kamphuis SSM, Smith V, van den Berg JM.
    Nailfold capillary scleroderma pattern may be associated with disease damage in childhood-onset systemic lupus erythematosus: important lessons from longitudinal follow-up.
    Lupus Sci Med. 2022 Feb;9(1):e000572. doi: 10.1136/lupus-2021-000572.
    https://pubmed.ncbi.nlm.nih.gov/35140136/

  • Bridges J, Chung KW, Martz CD, Smitherman EA, Drenkard C, Wu C, Lin J, Lim SS, Chae DH.
    Leukocyte Telomere Length and Childhood Onset of Systemic Lupus Erythematosus in the Black Women's Experiences Living with Lupus Study.
    ACR Open Rheumatol. 2022 Feb 17. doi: 10.1002/acr2.11411. 
    https://pubmed.ncbi.nlm.nih.gov/35178897/

  • Lerkvaleekul B, Apiwattanakul N, Tangnararatchakit K, Jirapattananon N, Srisala S, Vilaiyuk S.
    Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus.
    PLoS One. 2022 Feb 7;17(2):e0263536. doi: 10.1371/journal.pone.0263536. 
    https://pubmed.ncbi.nlm.nih.gov/35130317/

 
ENERO 2022
  • Alexander T, Hedrich CM.
    Systemic lupus erythematosus - Are children miniature adults?
    Clin Immunol. 2022 Jan;234:108907.doi: 10.1016/j.clim.2021.108907.
    https://pubmed.ncbi.nlm.nih.gov/34890808/ 

  • Dasdemir S, Yildiz M, Celebi D, Sahin S, Aliyeva N, Haslak F, Gunalp A, Adrovic A, Barut K, Artim Esen B, Kasapcopur O.
    Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel.
    Lupus. 2022 Jan 27:9612033221076733. doi: 10.1177/09612033221076733.
    https://pubmed.ncbi.nlm.nih.gov/35086391/

  • Anuwutnavin S, Chuenchitkultavorn V, Nitiyarom R, Rekhawasin T, Kanjanauthai S, Sompagdee N.
    Prenatal predisposing factors associated with neonatal lupus erythematosus.
    Lupus. 2022 Jan;31(1):77-88. doi: 10.1177/09612033211066455.
    https://pubmed.ncbi.nlm.nih.gov/34978218/

  • Sontichai W, Liao F, Dominguez D, Levy DM, Al Mutairi M, Ng L, Silverio F, Silverman ED, Wasserman JD, Hiraki LT.
    Timing of Childhood-Onset Systemic Lupus Erythematosus Diagnosis Relative to Menarche and the Impact on Final Adult Height.
    Arthritis Care Res (Hoboken). 2022 Feb;74(2):199-207. doi: 10.1002/acr.24461.
    https://pubmed.ncbi.nlm.nih.gov/32976694/

DICIEMBRE 2021
  • Andrade Balbi V, Artur Silva C, Nascimento Pedrosa T, Rodrigues Pereira RM, de Arruda Campos LM et al.
    Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis.
    Lupus. 2021 Dec 29;9612033211062515. doi: 10.1177/09612033211062515. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34965782/

  • Johnson SR, Gladman DD, Brunner HI, Isenberg D, Clarke AE et al.
    Evaluating the construct of damage in systemic lupus erythematosus.
    Arthritis Care Res (Hoboken). 2021 Dec 28. doi: 10.1002/acr.24849. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34962100/

  • Enocsson H, Karlsson J, Li HY, Wu Y, Kushner I, Wetterö J, C Sjöwall.
    The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus.
    J Clin Med. 2021 Dec 13;10(24):5837. doi: 10.3390/jcm10245837.
    https://pubmed.ncbi.nlm.nih.gov/34945133/

  • Wang  W, Yue C, Gao S, Li S, Zhou J, Chen J, Fu J, Sun W, Hua C.
    Promising Roles of Exosomal microRNAs in Systemic Lupus Erythematosus.
    Front Immunol. 2021 Dec 13;12:757096. doi: 10.3389/fimmu.2021.757096. eCollection 2021.
    https://pubmed.ncbi.nlm.nih.gov/34966383/

  • Bakutenko IY, Haurylchyk ID, Nikitchenko NV, Sechko EV et al.
    Neutrophil cytosolic factor 2 (NCF2) gene polymorphism is associated with juvenile-onset systemic lupus erythematosus, but probably not with other autoimmune rheumatic diseases in children.
    Mol Genet Genomic Med. 2021 Dec 31;e1859. doi: 10.1002/mgg3.1859. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34971477/

 
NOVIEMBRE 2021
  • Valenzuela-Almada MO, Hocaoglu M, Dabit JY, Osei-Onomah SA, Basiaga ML, Orandi AB, Giblon RE, Barbour KE, Crowson CS, Duarte-García A.
    Epidemiology of Childhood-Onset Systemic Lupus Erythematosus: A Population-Based Study.
    Arthritis Care Res (Hoboken). 2021 Nov 25. doi: 10.1002/acr.24827. Epub ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34825516/

  • Zorn-Pauly L, von Stuckrad ASL, Klotsche J, Rose T, Kallinich T, Enghard P, Ostendorf L, Burns M, Doerner T, Meisel C, Schneider U, Unterwalder N, Burmester G, Hiepe F, Alexander T, Biesen R.
    Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus.
    Rheumatology (Oxford). 2021 Nov 27:keab875. doi: 10.1093/rheumatology/keab875. Epub ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34849605/

  • Rubinstein TB, Dionizovik-Dimanovski M, Davis AM, Smith C, Faust L, Rutstein B, Mitchell M, Jones JT, Harris JG, Rodriguez M, Tesher M, Onel K, Gabbay V, Stein RE, von Scheven E, Knight AM; and for the CARRA Mental Health Workgroup.
    Multicenter study of utility and acceptability of depression and anxiety screening in adolescents and young adults with childhood-onset systemic lupus.
    Arthritis Care Res (Hoboken). 2021 Nov 21. doi: 10.1002/acr.24825. Epub ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34806329/

OCTUBRE 2021
  • Pitta AC, Silva CA, Insfrán CE, Pasoto SG, Trindade VC, Novak GV, Sakamoto AP, Terreri MT, Pereira RM, Magalhães CS, Fonseca AR, Islabão AG, Assad AP, Buscatti IM, Elias AM, Piotto DP, Ferriani VP, Carvalho LM, Rabelo Junior CN, Marini R, Sztajnbok FR, Sacchetti SB, Bica BE, Moraes AJ, Robazzi TC, Lotufo S, Cavalcanti AS, Naka EN, Carneiro-Sampaio M, Bonfá E, Aikawa NE; Brazilian Childhood-onset Systemic Lupus Erythematosus Group.
    The new 2019-EULAR/ACR classification criteria specific domains at diagnosis can predict damage accrual in 670 childhood-onset systemic lupus erythematosus patients.
    Lupus. 2021 Oct 25:9612033211054397. doi: 10.1177/09612033211054397. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34689652/

  • Deng WP.
    Recent advances in the treatment of systemic lupus erythematosus with belimumab in children
    Zhongguo Dang Dai Er Ke Za Zhi. 2021 Oct 15;23(10):1069-1074. 
    https://pubmed.ncbi.nlm.nih.gov/34719425/

  • De Mutiis C, Wenderfer SE, Orjuela A, Bagga A, Basu B, Sar T, et al.
    Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis.
    Rheumatology (Oxford). 2021 Oct 9:keab746. doi: 10.1093/rheumatology/keab746. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34626102/

  • Giani T, Smith EM, Al-Abadi E, Armon K, Bailey K, Ciurtin C, et al; UK JSLE Cohort Study.
    Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study.
    Lupus. 2021 Oct 2:9612033211045050. doi: 10.1177/09612033211045050. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34601989/

  •  Tarçın G, Karakaş H, Şahin S, Turan H, Yıldız M, Özer Y, et al.
    Insulin resistance in children with juvenile systemic lupus erythematosus and investigation of the possibly responsible factors.
    Clin Rheumatol. 2021 Oct 7. doi: 10.1007/s10067-021-05952-9. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34617197/

SEPTIEMBRE 2021
  • Brunner HI, Abud-Mendoza C, Mori M, Pilkington CA, Syed R, Takei S, Viola DO, Furie RA, Navarra S, Zhang F, Bass DL, Eriksson G, Hammer AE, Ji BN, Okily M, Roth DA, Quasny H, Ruperto N.
    Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison.
    RMD Open. 2021 Sep;7(3):e001747. doi: 10.1136/rmdopen-2021-001747.
    https://pubmed.ncbi.nlm.nih.gov/34531304/

  • Eesa NN, Abdel Nabi H, Owaidy RE, Khalifa I, Radwan AR, NourEl-Din AM, et al; Egyptian College of Rheumatology (ECR) SLE Study Group.
    Systemic lupus erythematosus children in Egypt: Homeland spectrum amid the global situation.
    Lupus. 2021 Sep 16:9612033211043010. doi: 10.1177/09612033211043010. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34528835/

  • Sete MRC, Carlos JC, Mello-Neto JM, Lira-Junior R, Brito F, Bostrom EA, Sztajnbok FR, Figueredo CM.
    Impact of chronic gingivitis management on the cytokine and anti-PPAD expressions in juvenile systemic lupus erythematosus: A six-month follow-up
    J Periodontal Res. 2021 Sep 12. doi: 10.1111/jre.12924. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34510434/

AGOSTO 2021
  • Ramirez GA, Argolini LM, Bellocchi C, Moroni L, Della-Torre E, Farina N, et al.
    Impact of the COVID-19 pandemic in patients with systemic lúpus erythematosus throughout one year.
    Clin Immunol. 2021 Aug 31;231:108845. doi: 10.1016/j.clim.2021.108845. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34478882/

  • Gilbert M, Goilav B, Hsu JJ, Nietert PJ, Meidan E, Chua A, Ardoin SP, Wenderfer SE, Akca ÜK, Batu ED, Kısaarslan AP, Poyrazoğlu H, Ayaz NA, Sözeri B, Sağ E, Atalay E, Demir S, Karadağ ŞG, Demir F, Bilginer Y, Gümrük F, Özen S.
    Hematological involvement in pediatric systemic lúpus erythematosus: A multi-center study.
    Lupus. 2021 Aug 28:9612033211038824. doi: 10.1177/09612033211038824. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34459313/

  • von Scheven E, Ruth NM; Pediatric Nephrology and Rheumatology Collaborative Group, the Childhood Arthritis and Rheumatology Research Alliance, and the American Society for Pediatric Nephrology.
    Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE.
    Pediatr Rheumatol Online J. 2021 Aug 30;19(1):137. doi: 10.1186/s12969-021-00627-w.
    https://pubmed.ncbi.nlm.nih.gov/34461932/

  • Wasik H, Chadha V, Galbiati S, Warady B, Atkinson M.
    Dialysis Outcomes for Children With Lupus Nephritis Compared to Children With Other Forms of Nephritis: A Retrospective Cohort Study.
    Am J Kidney Dis. 2021 Aug 27:S0272-6386(21)00825-8. doi: 10.1053/j.ajkd.2021.07.013. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34461164/

  • Hubbard EL, Grammer AC, Lipsky PE.
    Transcriptomics data: pointing the way to subclassification and personalized medicine in systemic lúpus erythematosus
    Curr Opin Rheumatol. 2021 Aug 18. doi: 10.1097/BOR.0000000000000833. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34410228/

 JULIO 2021
  • Chalhoub NE, Wenderfer SE, Levy DM, Rouster-Stevens K, Aggarwal A, Savani SI, et al; Childhood Arthritis, Rheumatology Research Alliance Lupus Nephritis Work Group, the Pediatric Rheumatology European Society Lupus Working Party.
    International Consensus For The Dosing Of Corticosteroids In Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis.
    Arthritis Rheumatol. 2021 Jul 19. doi: 10.1002/art.41930. Epub ahead of print. PMID: 34279063.
    https://pubmed.ncbi.nlm.nih.gov/34279063/ 

  • Vazzana KM, Daga A, Goilav B, Ogbu EA, Okamura DM, Park C, Sadun RE, Smitherman EA, Stotter BR, Dasgupta A, Knight AM, Hersh AO, Wenderfer SE, Lewandowski LB; CARRA Registry investigators.
    Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort.
    Lupus. 2021 Jul 4:9612033211028658. doi: 10.1177/09612033211028658. Epub ahead of print. PMID: 34219529.
    https://pubmed.ncbi.nlm.nih.gov/34219529/

  • Ye Q, Wang G, Lu J, Huang Y, Zhang J, Zhu L, Zhu Y, Lan J, Li Z, Liu Y, Xu H, Li Z.
    Exposure levels of mycophenolic acid are associated with comorbidities in children with systemic lupus erythematosus.
    Lupus. 2021 Jul 26:9612033211034555. doi: 10.1177/09612033211034555. Epub ahead of print. PMID: 34304630.
    https://pubmed.ncbi.nlm.nih.gov/34304630/

  • Trindade VC, Carneiro-Sampaio M, Bonfa E, Silva CA.
    An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.
    Paediatr Drugs. 2021 Jul;23(4):331-347. doi: 10.1007/s40272-021-00457-z. Epub 2021 Jul 10. PMID: 34244988; PMCID: PMC8270778.
    https://pubmed.ncbi.nlm.nih.gov/34244988/

  • Frittoli RB, Pereira DR, Lapa AT, Postal M, Sinicato NA, Fernandes PT, Cendes F, Castellano G, Rittner L, Marini R, Niewold TB, Appenzeller S.
    Axonal dysfunction is associated with interferon-γ levels in childhood-onset systemic lupus erythematosus: a multivoxel magnetic resonance spectroscopy study.
    Rheumatology (Oxford). 2021 Jul 20:keab530. doi: 10.1093/rheumatology/keab530. Epub ahead of print. PMID: 34282445.
    https://pubmed.ncbi.nlm.nih.gov/34282445/

  • Greenan-Barrett J, Doolan G, Shah D, Virdee S, Robinson GA, Choida V, Gak N, de Gruijter N, Rosser E, Al-Obaidi M, Leandro M, Zandi MS, Pepper RJ, Salama A, Jury EC, Ciurtin C.
    Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus.
    Int J Mol Sci. 2021 Jul 16;22(14):7619. doi: 10.3390/ijms22147619. PMID: 34299237; PMCID: PMC8306911.
    https://pubmed.ncbi.nlm.nih.gov/34299237/

  • Mosaad YM, Hammad A, AlHarrass MF, Sallam R, Shouma A, Hammad E, Ahmed EO, Abdel-Azeem HA, Sherif D, Fawzy I, Elbahnasawy A, Abdel Twab H.
    ARID5B rs10821936 and rs10994982 gene polymorphism and susceptibility to juvenile systemic lupus erythematosus and lupus nephritis.
    Lupus. 2021 Jul;30(8):1226-1232. doi: 10.1177/09612033211010338. Epub 2021 Apr 22. PMID: 33888010.
    https://pubmed.ncbi.nlm.nih.gov/33888010/

JUNIO 2021
  • Sandy C Bergkamp, Dieneke Schonenberg-Meinema, Amara Nassar-Sheikh Rashid et al.
    Reliable detection of subtypes of nailfold capillary haemorrhages in childhood-onset systemic lupus erythematosus.
    Clin Exp Rheumatol. 2021 Jun 8. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/34128796/

  • Imran S, Thabah MM, Azharudeen M, Ramesh A, Bobby Z, Negi VS.
    Liver Abnormalities in Systemic Lupus Erythematosus: A Prospective Observational Study.
    Cureus. 2021 Jun 16;13(6):e15691. doi: 10.7759/cureus.15691.
    https://pubmed.ncbi.nlm.nih.gov/34277279/

MAYO 2021
  • Case S, Sinnette C, Phillip C, Grosgogeat C, Costenbader KH, Leatherwood C, Feldman CH, Beth Son M.
    Patient experiences and strategies for coping with SLE: A qualitative study.
    Lupus. 2021 May 20:9612033211016097. doi:10.1177/09612033211016097
    https://pubmed.ncbi.nlm.nih.gov/34013818/

  • Soliman SA, Haque A, Mason S, Greenbaum LA, Hicks MJ, Mohan C, Wenderfer SE.
    Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research Consortium.
    Lupus. 2021 May 14:9612033211016100. doi:10.1177/09612033211016100
    https://pubmed.ncbi.nlm.nih.gov/33990158/

  • K Akca Ü, Batu ED, Kısaarslan AP, Poyrazoğlu H, Ayaz NA, Sözeri B, Sağ E, Atalay E, Demir S, Karadağ ŞG, Demir F, Bilginer Y, Gümrük F, Özen S.
    Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study.
    Lupus. 2021 May 6:9612033211014271. doi:10.1177/09612033211014271
    https://pubmed.ncbi.nlm.nih.gov/33951967/

ABRIL 2021 

MARZO 2021
  • Smith EMD, Rasul S, Ciurtin C, Al-Abadi E, Armon K, Bailey K, Brennan M, Gardner-Medwin J, Haslam K, Hawley DP, Lane S, Leahy A, Leone V, Malik G, Mewar D, Moots R, Pilkington C, Ramanan AV, Rangaraj S, Ratcliffe A, Riley P, Sen E, Sridhar A, Wilkinson N, Beresford MW, McCann LJ, Hedrich CM.
    Limited sensitivity and specificity of ACR/EULAR-2019 classification criteria for SLE in JSLE? - Observations from the UK JSLE Cohort Study
    Rheumatology (Oxford). 2021 Mar 4:keab210. doi: 10.1093/rheumatology/keab210. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/33690793/ 

  • Cinar OK, Marlais M, Al Obaidi M, Cheng IL, Tullus K, Brogan P, Moraitis E.
    Ofatumumab use in juvenile systemic lupus erythematosus: A single centre experience.
    Lupus. 2021 Mar;30(3):527-530. doi: 10.1177/0961203320981137.
    https://pubmed.ncbi.nlm.nih.gov/33327846/

  • Osmani Z, Schrama TJ, Zacouris-Verweij W, Andersen J, Frankel S, Bultink IEM, Cornet A, van Vollenhoven RF.
    Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence.
    Lupus Sci Med. 2021 Mar;8(1):e000478. doi: 10.1136/lupus-2021-000478.
    https://pubmed.ncbi.nlm.nih.gov/33795484/

  •  Robinson GA, Waddington KE, Coelewij L, Peng J, Naja M, Wincup C, Radziszewska A, Peckham H, Isenberg DA, Ioannou Y, Ciurtin C, Pineda-Torra I, Jury EC.
    Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE.
    EBioMedicine. 2021 Mar;65:103243. doi: 10.1016/j.ebiom.2021.103243. 
    https://pubmed.ncbi.nlm.nih.gov/33640328/

     

FEBRERO 2021
  • AlAhmed O, Way A, Akoghlanian S, Barbar-Smiley F, Lemle S, MacDonald D, Frost E, Wise K, Lee L, Ardoin SP, Sivaraman V.
    Improving eye screening practice among pediatric rheumatology patients receiving hydroxychloroquine.
    Lupus. 2021 Feb;30(2):269-279. doi: 10.1177/0961203320979038. Epub 2020 Dec 13. PMID: 33307983.
    https://pubmed.ncbi.nlm.nih.gov/33307983/
ENERO 2021
DICIEMBRE 2020
  • Baglan E, Ozdel S, Uysal Yazıcı M, Azapağası E, Çelik H, Yüksel D, Uçan B, Karakaya D, Bulbul M.
    A novel therapeutic approach using the Zipper method to treat chorea in a pediatric-onset systemic lupus erythematosus patient.
    Lupus. 2021 Jan 7:961203320984013. doi: 10.1177/0961203320984013. Epub ahead of print. PMID: 33413004
    https://pubmed.ncbi.nlm.nih.gov/33413004/

  • Cinar OK, Marlais M, Al Obaidi M, Cheng IL, Tullus K, Brogan P, Moraitis E.
    Ofatumumab use in juvenile systemic lupus erythematosus: A single centre experience.
    Lupus. 2020 Dec 16:961203320981137
    https://pubmed.ncbi.nlm.nih.gov/33327846/
  • Turnier JL, Pachman LM, Lowe L, Tsoi LC, Elhaj S, Menon R, Amoruso MC, Morgan GA, Gudjonsson JE, Berthier CC, Kahlenberg JM.
    Comparison of lesional juvenile myositis and lupus skin reveals overlapping yet unique disease pathophysiology.
    Arthritis Rheumatol. 2020 Dec 10. doi: 10.1002/art.41615
    https://pubmed.ncbi.nlm.nih.gov/33305541/
  • Ishikawa M, Mori T, Yamamoto T.
    Neonatal lupus erythematosus exacerbated by vaccination.
    J Dermatol. 2020 Dec;47(12):1450-1453
    https://pubmed.ncbi.nlm.nih.gov/32881039/
NOVIEMBRE 2020
  • Batu ED, Kaya Akca U, Pac Kısaarslan A, Sağ E, Demir F, Demir S, Özdemir Çiçek S, Poyrazoglu H, Sozeri B, Bilginer Y, Ozen S.
    The performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 classification criteria in pediatric systemic lupus erythematosus.
    J Rheumatol. 2020 Nov 15:jrheum.200871. doi: 10.3899/jrheum.200871.
    https://pubmed.ncbi.nlm.nih.gov/33191281/
  • El-Garf K, El-Garf A, Gheith R, Badran S, Salah S, Marzouk H, Farag Y, Khalifa I, Mostafa N.
    A comparative study between the disease characteristics in adult-onset and childhood-onset systemic lupus erythematosus in Egyptian patients attending a large university hospital.
    Lupus. 2020 Nov 11:961203320972778. DOI:10.1177/0961203320972778
    https://pubmed.ncbi.nlm.nih.gov/33175664/
  • Yan HB, Li YM.
    Atrial thrombus as a complication of SLE and APS in an 8-year-old child.
    Pediatr Rheumatol Online J. 2020 Nov 17;18(1):90.
    https://pubmed.ncbi.nlm.nih.gov/33203428/
  • Abo-Shanab AM, Kholoussi S, Kandil R, Dorgham D.
    Cytokines, 25-OH vit D and disease activity in patients with juvenile-onset systemic lupus erythematosus.
    Lupus. 2020 Nov 12:961203320973068. DOI:10.1177/0961203320973068
    https://pubmed.ncbi.nlm.nih.gov/33183127/
  • Fogaça da Mata M, Rebelo M, Sousa HS, Rocha A, Miguel P, Oliveira Ramos F, Costa-Reis P.
    Sinus node disfunction in an adolescent with systemic lupus erythematosus.
    Lupus. 2020 Nov 20:961203320974091. DOI: 10.1177/0961203320974091
    https://pubmed.ncbi.nlm.nih.gov/33215560/
 
OCTUBRE 2020
  • AlAhmed O, Sivaraman V, Moore-Clingenpeel M, Ardoin SP, Bout-Tabaku S; CARRA registry investigators.
    Autoimmune thyroid diseases, autoimmune hepatitis, celiac disease and type 1 diabetes mellitus in pediatric systemic lupus erythematosus: Results from the CARRA Legacy Registry.
    Lupus. 2020 Oct 4:961203320961469. doi: 10.1177/0961203320961469. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/33016198/
  • Colucci M, Ruggiero B, Gianviti A, Rosado MM, Carsetti R, Bracaglia C, De Benedetti F, Emma F, Vivarelli M.
    IgM on the surface of T cells: a novel biomarker of pediatric-onset systemic lupus erythematosus.
    Pediatr Nephrol. 2020 Oct 6. doi: 10.1007/s00467-020-04761-7. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/33025206/
  • Ogbu EA, Chandrakasan S, Rouster-Stevens K, Greenbaum LA, Sanz I, Gillespie SE, Marion C, Okeson K, Prahalad S.
    Impact of autoimmune cytopenias on severity of childhood-onset systemic lupus erythematosus: A single-center retrospective cohort study.
    Lupus. 2020 Oct 27:961203320969806. doi: 10.1177/0961203320969806. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/33108953/

  • Treemarcki EB, Hersh AO.
    Health-Related Quality of Life Measures in Childhood-Onset Systemic Lupus Erythematosus.
    Arthritis Care Res (Hoboken). 2020 Oct;72 Suppl 10:593-607. doi: 10.1002/acr.24374.
    https://pubmed.ncbi.nlm.nih.gov/33091261/

  • Stuckrad SLV, Klotsche J, Biesen R, Lieber M, Thumfart J, Meisel C, Unterwalder N, Kallinich T.
    SIGLEC1 (CD169) is a sensitive biomarker for the deterioration of the clinical course in childhood systemic lupus erythematosus.
    Lupus. 2020 Oct 20:961203320965699. doi: 10.1177/0961203320965699. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/33081587/

 
SEPTIEMBRE 2020
  • Peng L, Wu C, Hong R, Sun Y, Qian J, Zhao J, Wang Q, Tian X, Wang Y, Li M, Zeng X.
    Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis.
    Ther Adv Musculoskelet Dis. 2020 Sep 14;12:1759720X20953336. doi: 10.1177/1759720X20953336.
    https://pubmed.ncbi.nlm.nih.gov/32973935/
  • Kallas R, Goldman D, Petri MA.
    Cutaneous vasculitis in SLE.
    Lupus Sci Med. 2020 Sep;7(1):e000411. doi: 10.1136/lupus-2020-000411.
    https://pubmed.ncbi.nlm.nih.gov/32963114/

  • Yang Z, Cheng C, Wang Z, Wang Y, Zhao J, Wang Q, Tian X, Hsieh E, Li M, Zeng X.
    Prevalence, predictors and prognostic benefits of remission achievement in patients with systemic lupus erythematosus: a systematic review.
    Arthritis Care Res (Hoboken). 2020 Sep 28. doi: 10.1002/acr.24464. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32986933/
  • Ward NKZ, Linares-Koloffon C, Posligua A, Gandrabur L, Kim WY, Sperber K, Wasserman A, Ash J.
    Cardiac Manifestations of Systemic Lupus Erythematous: An Overview of the Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology and Treatment Options.
    Cardiol Rev. 2020 Sep 24. doi: 10.1097/CRD.0000000000000358. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32991394/

  • Huybrechts KF, Bateman BT, Zhu Y, Straub L, Mogun H, Kim SC, Desai RJ, Hernandez-Diaz S.
    Hydroxychloroquine early in Pregnancy and Risk of Birth Defects.
    Am J Obstet Gynecol. 2020 Sep 19:S0002-9378(20)31064-4. doi: 10.1016/j.ajog.2020.09.007. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32961123/   

  • Mo HY, Wei JCC, Chen XH, Chen HH.
    Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia: a nationwide population-based cohort study.
    Ann Rheum Dis. 2020 Sep 22:annrheumdis-2020-218886. doi: 10.1136/annrheumdis-2020-218886.
    https://pubmed.ncbi.nlm.nih.gov/32963051/

  • Blanchet B, Jallouli M, Allard M, Ghillani-Dalbin P, Galicier L, Aumaître O, et al
    Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence.
    Arthritis Res Ther. 2020 Sep 25;22(1):223. doi: 10.1186/s13075-020-02291-z.
    https://pubmed.ncbi.nlm.nih.gov/32977856/

  • AlEnzi F, Yateem M, Shaikh M, AlSohaibani F, Alhaymouni B, Ahmed A, Al-Mayouf SM.
    The Value of Screening for Celiac Disease in Systemic Lupus Erythematosus: A Single Experience of a Tertiary Medical Center.
    Rheumatol Ther. 2020 Sep;7(3):649-656. doi: 10.1007/s40744-020-00223-6.
    https://pubmed.ncbi.nlm.nih.gov/32705576/

  • Sontichai W, Liao F, Dominguez D, Levy DM, Al Mutairi M, Ng L, Silverio F, Silverman ED, Wasserman JD, Hiraki LT.
    Timing of Childhood-onset Systemic Lupus Erythematosus Diagnosis Relative to Menarche Impacts Final Height.
    Arthritis Care Res (Hoboken). 2020 Sep 25. doi: 10.1002/acr.24461. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32976694/

  • Tsai HL, Chang JW, Lu JH, Liu CS.
    Epidemiology and risk factors for avascular necrosis in childhood systemic lupus erythematosus in a Taiwanese population.
    Sci Rep. 2020 Sep 23;10(1):15563. doi: 10.1038/s41598-020-71923-w.
    https://pubmed.ncbi.nlm.nih.gov/32968109/

  • Yavuz S, Bianchi M, Kozyrev S, Bolin K, Leonard D, Pucholt P, Sandling JK, Bengtsson A, Jönsen A, Rantapää-Dahlqvist S, Sjöwall C, Svenungsson E, Gunnarsson I, Lindblad-Toh K, Rönnblom L.
    Toll-like receptors revisited; a possible role for TLR1 in lupus nephritis.
    Ann Rheum Dis. 2020 Sep 29:annrheumdis-2020-218373. doi: 10.1136/annrheumdis-2020-218373. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32994161/

 
AGOSTO 2020
  • AlEnzi F, Yateem M, Shaikh M, AlSohaibani F, Alhaymouni B, Ahmed A, Al-Mayouf SM.
    The Value of Screening for Celiac Disease in Systemic Lupus Erythematosus: A Single Experience of a Tertiary Medical Center
    Rheumatol Ther. 2020 Sep;7(3):649-656. doi: 10.1007/s40744-020-00223-6. Epub 2020 Jul 23
    https://pubmed.ncbi.nlm.nih.gov/32705576/
  • Aljaberi N, Nguyen K, Strahle C, Merritt A, Mathur A, Brunner HI.
    The Performance of the New 2019-EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus in Children and Young Adults.
    Arthritis Care Res (Hoboken). 2020 Aug 25. doi: 10.1002/acr.24430.
    https://pubmed.ncbi.nlm.nih.gov/32841547/
  • Sršen S, Frković M, Malčić I, Jelušić M
    Rituximab in Treatment of Children with Refractory Vasculitis and Systemic Lupus Erythematosus - Single Center Experience in Croatia
    Acta Dermatovenerol Croat. 2020 Aug;28(2):63-69.
    https://pubmed.ncbi.nlm.nih.gov/32876030/
  • Torres Saavedra FA, Ramirez Campo L, Velasquez Mendez M, Mejia Barreneche N, Vargas Suaza GA, Ruiz Restrepo JD,Martinez-Gomez M.
    Bullous lupus as the first manifestation of systemic lupus erythematosus in the pediatric population: A diagnostic challenge in daily practice
    Lupus.2020 Aug 25;961203320950814. doi: 10.1177/0961203320950814.
    https://pubmed.ncbi.nlm.nih.gov/32842868/
  • Ganguli SK, Hui-Yuen JS, Jolly M, Cerise J, Eberhard BA.
    Performance and psychometric properties of lupus impact tracker in assessing patient-reported outcomes in pediatric lupus: Report from a pilot study.
    Lupus. 2020 Aug 24:961203320951264. doi: 10.1177/0961203320951264.
    https://pubmed.ncbi.nlm.nih.gov/32838619/
     
JULIO 2020
  • Davis A, Chang J, Shapiro S, Klein-Gitelman M, Faerber J, Katcoff H, Cidav Z, Mandell DS, Knight A.
    Immunomodulatory Medication Use in Newly-Diagnosed Youth with Systemic Lupus Erythematosus.
    Arthritis Care Res (Hoboken). 2020 Jul 23. doi: 10.1002/acr.24392. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32702144/
  • Brunner HI, Abud-Mendoza C, Viola DO, Calvo Penades I, Levy D, Anton J, Calderon JE, Chasnyk VG, Ferrandiz MA, Keltsev V, Paz Gastanaga ME, Shishov M, Boteanu AL, Henrickson M, Bass D, Clark K, Hammer A, Ji BN, Nino A, Roth DA, Struemper H, Wang ML, Martini A, Lovell D, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
    Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial.
    Ann Rheum Dis. 2020 Jul 22;annrheumdis-2020-217101. doi: 10.1136/annrheumdis-2020-217101. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32699034/
  • Aygun D, Kuskucu MA, Sahin S, Adrovic A, Barut K, Yıldız M, Sharifova S, Midilli K, Cokugras H, Camcıoglu Y, Kasapcopur O.
    Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
    Lupus. 2020 Jul 9:961203320940029. doi: 10.1177/0961203320940029. Epub ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32646294/
  • Oni L, Wright RD, Marks S, Beresford MW, Tullus K.
    Kidney outcomes for children with lupus nephritis.
    Pediatr Nephrol. 2020 Jul 28. doi: 10.1007/s00467-020-04686-1. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32725543/

  • Emara M, Hafez MA, El-Bendary A, Razaky OE.
    Speckle tracking echocardiography for the evaluation of left ventricular function in children with systemic lupus erythematosus.
    Lupus. 2020 Jul 28:961203320942296. doi: 10.1177/0961203320942296. Epub ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32723060/

  • Asmiyou A, Bakr AM, Shahin DA, Wahba Y.
    CD40 and CD72 expression and prognostic values among children with systemic lupus erythematosus: a case-control study.
    Lupus. 2020 Jul 22:961203320941931. doi: 10.1177/0961203320941931. Epub ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32700598/

 
JUNIO 2020
  • Guleria S, Jindal A, Pilania R, Bhattarai D, Kaur A, Naganur S, Pandiarajan V, Suri D, Singh S.
    An uncommon overlap of two common rheumatological disorders.
    Lupus. 2020 Jun 9:961203320930101. doi: 1.1177/0961203320930101
    https://pubmed.ncbi.nlm.nih.gov/32515654/
  • Elkoumi MA, Allah MA, Mohamed FY, Boraey NF, Abdellatif SH, Shehab MM, Sherif AH, Akeel NE, Saleh RM, Elshreif AM, Abdelrahman HM, Soliman AA, Emam AA, Youssef MA, Fahmy DS, Sallam MM, Nawara AM, Elgohary EA, Ismael A, El-Kaffas SM, Sobeih AA, Ibrahim LM, Ibrahim MA, Abdou AM, Yousry SM, Osman SF, El-Deeb FM, Elhewala AA, Hafez SF, Waked NM, Elbasyouni HA, Fouad RA, Zeidan NM, Nashat M, Farghaly MA.
    Association of interleukin-17A gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multi-centre study.
    Lupus. 2020 Jun;29(7):767-775. doi: 10.1177/0961203320922305
    https://pubmed.ncbi.nlm.nih.gov/32380889/

MAYO 2020
          • Harry O, Crosby LE, Mara C, Ting TV, Huggins JL, Modi AC.
            Feasibility and acceptability of an innovative adherence intervention for young adults with childhood-onset systemic Lupus Erythematosus.
            Pediatr Rheumatol Online J. 2020 Apr 26;18(1):36.
            https://doi.org/10.1186/s12969-020-00430-z
          • Zhao J, Chen Q, Zhu Y, Zhao M, Liu J, Zhang Z, Gong X.
            Nephrological disorders and neurological involvement in pediatric primary Sjogren syndrome:a case report and review of literature.
            Pediatr Rheumatol Online J. 2020 May 24;18(1):39.
            https://doi.org/10.1186/s12969-020-00431-y
          • Sawalha AH, Manzi S.
            Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus.
            Eur J Rheumatol. 2020 Apr 8. doi: 10.5152/eurjrheum.2020.20055. Online ahead of print.
            https://pubmed.ncbi.nlm.nih.gov/32352359
          • Limaye MA, Buyon JP, Cuneo BF, Mehta-Lee SS.
            A review of fetal and neonatal consequences of maternal systemic lupus erythematosus.
            Prenat Diagn. 2020 Apr 13. doi: 10.1002/pd.5709. Online ahead of print.
            https://pubmed.ncbi.nlm.nih.gov/32282083
          • Bitencourt N, Solow EB, Wright T, Bermas BL
            Inflammatory myositis in systemic lupus erythematosus
            Lupus. 2020 Apr 11:961203320918021. doi: 10.1177/0961203320918021. Online ahead of print.
            https://pubmed.ncbi.nlm.nih.gov/32281474
 
MARZO 2020
  • Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, et al.
    2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
    Ann Rheum Dis. 2020 Mar 27. pii: annrheumdis-2020-216924. doi: 10.1136/annrheumdis-2020-216924. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32220834
  • Parikh SV, Almaani S, Brodsky S, Rovin BH.
    Update on Lupus Nephritis: Core Curriculum 2020.
    Am J Kidney Dis. 2020 Mar 24. pii: S0272-6386(19)31170-9. doi: 10.1053/j.ajkd.2019.10.017. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32220510
  • Rúa-Figueroa Fernández de Larrinoa I, Pego-Reigosa JM; en representación de los investigadores del proyecto RELESSER y del grupo EAS-SER; Investigadores del registro RELESSER en su fase transversal.
    Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain.
    Reumatol Clin. 2020 Mar 20. pii: S1699-258X(20)30021-8. doi: 10.1016/j.reuma.2020.01.006. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32205082
  • Yamany A, Behiry ME, Ahmed SA.
    Hyponatremia as an Inflammatory Marker of Lupus Activity Is a Fact or Fad: A Cross-Sectional Study.
    Open Access Rheumatol. 2020 Mar 12;12:29-34.
    https://www.ncbi.nlm.nih.gov/pubmed/32210647
  • Maria NI, Davidson A.
    Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy.
    Nat Rev Rheumatol. 2020 Mar 19. doi: 10.1038/s41584-020-0401-9. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32203285
  • Elolemy G, Al Rashidi A, Dehrab A, Almathkouri A, Varghese A, Chikhly M, Alkhawaja F.
    Successful treatment of refractory lupus erythematosus profundus with the interleukin-6 antagonist tocilizumab: a case report.
    Lupus. 2020 Mar 19:961203320913944. doi: 10.1177/0961203320913944. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32192399
  • Tselios K, Gladman DD, Su J, Urowitz M.
    Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus.
    Ann Rheum Dis. 2020 Mar 10. pii: annrheumdis-2019-216764. doi: 10.1136/annrheumdis-2019-216764. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32156706
  • Cozier YC, Barbhaiya M, Castro-Webb N, Conte C, Tedeschi S, Leatherwood C, Costenbader KH, Rosenberg L.
    Association of Child Abuse with Systemic Lupus Erythematosus in Black Women During Adulthood.
    Arthritis Care Res (Hoboken). 2020 Mar 13. doi: 10.1002/acr.24188. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32170851
  • Luo W, Mao P, Zhang L, Chen X, Yang Z.
    Assessment of ovarian reserve by serum anti-Müllerian hormone in patients with systemic lupus erythematosus: a meta-analysis.
    Ann Palliat Med. 2020 Mar 3. pii: apm.2020.02.11. doi: 10.21037/apm.2020.02.11. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32156138
 
FEBRERO 2020
          • Cintrón D, Alanis JM, Álvarez-Villalobos N, Rodríguez-Gutiérrez R, Vilá LM.
            A systematic review of pharmacological therapies and their effectiveness on health-related quality of life outcomes in patients with juvenile-onset systemic lupus erythematosus.
            Lupus. 2020 Feb 7:961203320904145. doi: 10.1177/0961203320904145.
            https://www.ncbi.nlm.nih.gov/pubmed/32031032
          • Ogbu EA, Rouster-Stevens K, Vega-Fernandez P.
            Lupus Mesenteric Vasculitis: A Rare Initial Presentation of Pediatric Systemic Lupus Erythematosus.
            J Clin Rheumatol. 2020 Feb 5. doi: 10.1097/RHU.0000000000001317.
            https://www.ncbi.nlm.nih.gov/pubmed/32028306
          • Miguel DF, Terreri MT, Pereira RMR, Bonfá E, Silva CAA, Corrente JE, Magalhaes CS; Brazilian Childhood-onset Systemic Lupus Erythematosus Group.
            Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis.
            Adv Rheumatol. 2020 Feb 1;60(1):10. doi: 10.1186/s42358-020-0114-4.
            https://www.ncbi.nlm.nih.gov/pubmed/32005292
 
ENERO 2020
          • Webber D, Cao J, Dominguez D, Gladman DD, Levy DM, Ng L, Paterson AD, Touma Z, Urowitz MB, Wither JE, Silverman ED, Hiraki LT.
            Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE.
            Rheumatology (Oxford). 2020 Jan 1;59(1):90-98. doi: 10.1093/rheumatology/kez220.
            https://www.ncbi.nlm.nih.gov/pubmed/31236574
          • Saxena A, Izmirly PM, Bomar RP, Golpanian RS, Friedman DM, Eisenberg R, Kim MY, Buyon JP.
            Factors associated with long-term cardiac dysfunction in neonatal lupus.
            Ann Rheum Dis. 2020 Feb;79(2):217-224. doi: 10.1136/annrheumdis-2019-215900. Epub 2019 Oct 31.
            https://www.ncbi.nlm.nih.gov/pubmed/31672776
 
 
DICIEMBRE 2019
          • Xu L, Zhang J, Pu R, Yue Z, Mo Y, Jiang X.
            Lupus Nephritis With Mild Asymptomatic Hypercalcemia in Children: A Case Report and Literature Review.
            Front Pediatr. 2019 Dec 6;7:507
            https://www.ncbi.nlm.nih.gov/pubmed/31867297
          • Borba VV, Shoenfeld Y.
            Breastfeeding in the systemic lupus erythematosus patient.
            Lupus. 2019 Dec;28(14):1737-1738
            https://www.ncbi.nlm.nih.gov/pubmed/31718450
          • Esteve-Valverde E, Tapiz-Reula A, Ruiz D, Alijotas-Reig J.
            Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria.
            Rheumatol Int. 2019 Dec 21. doi: 10.1007/s00296-019-04500-8
            https://www.ncbi.nlm.nih.gov/pubmed/31865445
          • Schonenberg-Meinema D, Melsens K, Nassar-Sheikh Rashid A, Cutolo M, Kuijpers TW, van den Berg JM, Smith V.
            Capillaroscopy in childhood-onset systemic lupus erythematosus: a first systematic review.
            Clin Exp Rheumatol. 2019 Dec 18.
            https://www.ncbi.nlm.nih.gov/pubmed/31858964
          • Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM.
            Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options.
            Clin Immunol. 2019 Dec;209:108274 doi: 10.1016/j.clim.2019.108274.
            https://www.ncbi.nlm.nih.gov/pubmed/31678365
 
 
OCTUBRE 2019
          • Liphaus BL, Lima L, Palmeira P, Silva CA, Goldenstein-Schainberg C, Carneiro-Sampaio M.
            Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus
            Clin Rheumatol. 2019 Oct 26. doi: 10.1007/s10067-019-04799-5. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/31655933
          • Kudose S, Santoriello D, Bomback AS, Stokes MB, D'Agati VD, Markowitz GS.
            Sensitivity and Specificity of Pathologic Findings to Diagnose Lupus Nephritis
            Clin J Am Soc Nephrol. 2019 Oct 25. pii: CJN.01570219. doi: 10.2215/CJN.01570219. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/31653670
          • Lee WF, Wu CY, Yang HY, Lee WI, Chen LC, Ou LS, Huang JL.
            Biomarkers associating endothelial Dysregulation in pediatric-onset systemic lupus erythematous
            Pediatr Rheumatol Online J. 2019 Oct 24;17(1):69. doi: 10.1186/s12969-019-0369-7.
            https://www.ncbi.nlm.nih.gov/pubmed/31651352
 
SEPTIEMBRE 2019
          • de Sousa LFA, Paupitz JA, Aikawa NE, Takayama L, Caparbo VF, Pereira RMR.
            Risk factors for bone loss in juvenile-onset systemic lupus erythematosus: a prospective study.
            Lupus. 2019 Sep;28(10):1224-1232. doi: 10.1177/0961203319869467. Epub 2019 Aug 14.
            https://www.ncbi.nlm.nih.gov/pubmed/31409184
          • Ali R, Hammad A, El-Nahrery E, Hamdy N, Elhawary AK, Eid R.
            Serum RANKL, osteoprotegerin (OPG) and RANKL/OPG ratio in children with systemic lupus erythematosus.
            Lupus. 2019 Sep;28(10):1233-1242. doi: 10.1177/0961203319867129. Epub 2019 Aug 12.
            https://www.ncbi.nlm.nih.gov/pubmed/31403902
          • Moraitis E, Stathopoulos Y, Hong Y, Al-Obaidi M, Mankad K, Hacohen Y, Sen D, Hemingway C, Eleftheriou D.
            Aquaporin-4 IgG antibody-related disorders in patients with juvenile systemic lupus erythematosus.
            Lupus. 2019 Sep;28(10):1243-1249. doi: 10.1177/0961203319855125. Epub 2019 Jun 18.
            https://www.ncbi.nlm.nih.gov/pubmed/31213132
          • Ma M, Hui-Yuen JS, Cerise JE, Iqbal S, Eberhard BA.
            Validation of the 2017 Weighted criteria compared to the 1997 ACR and the 2012 SLICC in Pediatric Systemic Lupus Erythematosus.
            Arthritis Care Res (Hoboken). 2019 Sep 3. doi: 10.1002/acr.24057. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31478595
          • Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR.
            2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.
            Arthritis Rheumatol. 2019 Sep;71(9):1400-1412. doi: 10.1002/art.40930. Epub 2019 Aug 6.
            https://www.ncbi.nlm.nih.gov/pubmed/31385462
          • Smitherman EA, Huang B, Furnier A, Taylor J, Burns MB, Brunner HI, Morgan EM.
            Quality of care in childhood-onset systemic lupus erythematosus: Report of an intervention to improve cardiovascular and bone health screening
            J Rheumatol. 2019 Sep 1. pii: jrheum.190295. doi: 10.3899/jrheum.190295. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31474591
          • Rodriguez-Smith J, Brunner HI.
            Update on the treatment and outcome of systemic lupus erythematous in children.
            Curr Opin Rheumatol. 2019 Sep;31(5):464-470.
            https://www.ncbi.nlm.nih.gov/pubmed/31107290
 
AGOSTO 2019
          • Restrepo-Escobar M, A Ríos N, Hernández-Zapata LJ, Velásquez M, Eraso R.
            Factors associated with infection amongst paediatric patients with systemic lupus erythematosus treated in the intensive care unit.
            Lupus. 2019 Aug;28(9):1141-1147.
            https://www.ncbi.nlm.nih.gov/pubmed/31256746
          • Contreras-Cubas C, García-Ortiz H, Velázquez-Cruz R, Barajas-Olmos F, Baca P, Martínez-Hernández A, Barbosa-Cobos RE, Ramírez-Bello J, López-Hernández MA, Svyryd Y, Mutchinick OM, Baca V, Orozco L.
            Catalytically Impaired TYK2 Variants are Protective Against Childhood- and Adult-Onset Systemic Lupus Erythematosus in Mexicans.
            Sci Rep. 2019 Aug 21;9(1):12165.
            https://www.ncbi.nlm.nih.gov/pubmed/31434951
          • Tanatar A, Çakan M, Karadağ ŞG, Kısaarslan AP, Sözeri B, Ayaz NA.
            The influence of carrying MEFV gene variants on juvenile systemic lupus erythematosus.
            Rheumatol Int. 2019 Aug 20. doi: 10.1007/s00296-019-04420-7.
            https://www.ncbi.nlm.nih.gov/pubmed/31432226
 
JULIO 2019
          • Tirosh I, Spielman S, Barel O, Ram R, Stauber T, Paret G, Rubinsthein M, Pessach IM, Gerstein M, Anikster Y, Shukrun R, Dagan A, Adler K, Pode-Shakked B, Volkov A, Perelman M, Greenberger S, Somech R, Lahav E, Majmundar AJ, Padeh S, Hildebrandt F, Vivante A.
            Whole exome sequencing in childhood-onset lupus frequently detects single gene etiologies.
            Pediatr Rheumatol Online J. 2019 Jul 30;17(1):52.
            https://www.ncbi.nlm.nih.gov/pubmed/31362757
          •  Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J et al.
            Antinuclear antibody-negative Systemic Lupus Erythematosus in an international inception cohort
            Arthr Care Res. 2019 Jul; 71(7):893-902.
            https://onlinelibrary.wiley.com/doi/10.1002/acr.23712
          • Wallace DJ, Ginzler EM, Merrill JT, Furie RA, Stohl W, Chatham WW, et al.
            Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus
            Arthritis Rheumatol. 2019 Jul; 71(7):1125-1134.
            https://onlinelibrary.wiley.com/doi/10.1002/art.40861
          • Peene I, Elewaut D
            Changing the Wolf from outside: how microbiota trigger systemic lupus erythematosus
            Ann Rheum Dis. 2019 Jul;78(7):947-956.
            https://ard-bmj-com.m-hdoct.a17.csinet.es/content/78/7/867
          • Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Robin BH et al.
            Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal.
            Ann Rheum Dis. 2019 Jul;78(7):947-956.
            https://www.ncbi.nlm.nih.gov/pubmed/30782585
          • Lowe CD, Brahe CA, Green B, Lam TK, Meyerle JH.
            Bullous systemic lupus erythematosus successfully treated with rituximab.
            Cutis. 2019 Jun;103(6):E5-E7
            https://www.ncbi.nlm.nih.gov/pubmed/31348461
 
JUNIO 2019
            • Moraitis E, Stathopoulos Y, Hong Y, Al-Obaidi M, Mankad K, Hacohen Y, Sen D, Hemingway C, Eleftheriou D.
              Aquaporin-4 IgG antibody-related disorders in patients with juvenile systemic lupus erythematosus.
              Lupus. 2019 Jun 18:961203319855125. doi: 10.1177/0961203319855125
              https://www.ncbi.nlm.nih.gov/pubmed/31213132
            • Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT.
              2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
              Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089
              https://www.ncbi.nlm.nih.gov/pubmed/30926722
            • Webber D, Cao J, Dominguez D, Gladman D, Levy DM, Ng L, Paterson AD, Touma Z, Urowitz MB, Wither JE, Silverman ED, Hiraki LT
              Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE.
              Rheumatology (Oxford). 2019 Jun 24. pii: kez220. doi: 10.1093/rheumatology/kez220
              https://www.ncbi.nlm.nih.gov/pubmed/31236574
            • Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, De Uña-Álvarez J, Balboa-Barreiro V, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Mouriño-Rodríguez C, Horcada L, Sánchez-Atrio A, Montilla C, Salgado E, Díez-Álvarez E, Blanco R, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JA, Gantes M, Hernández-Cruz B, Pecondón-Español A, Marras C, Bonilla G, Pego-Reigosa JM; RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER).
              Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).
              Semin Arthritis Rheum. 2019 Jun;48(6):1025-1029. doi: 10.1016/j.semarthrit.2018.09.005.
              https://www.ncbi.nlm.nih.gov/pubmed/30344081
 
ABRIL 2019
          • Santos FPST, Nascimento BR, Calderaro DC, Ferreira GA, Correa H.
            Neuropsychiatric Syndromes in Childhood-Onset Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis.
            J Clin Rheumatol. 2019 Apr 22. doi: 10.1097/RHU.0000000000001029. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/31022053
          • Gariup M, Lera-Miguel S, Torres F, Varela E, Serra-Pagès C, González-Navarro A, Espinosa G, Lázaro L, Cervera R, Morer A.
            Autoantibodies, elevated cytokines, and neurocognitive abnormalities in offspring of women with systemic lupus erythematosus: comparison with healthy controls.
            Clin Rheumatol. 2019 Apr 24. doi: 10.1007/s10067-019-04495-4. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/31020474
          • Chang JC, White BR, Elias MD, Xiao R, Knight AM, Weiss PF, Mercer-Rosa L.
            Echocardiographic Assessment of Diastolic Function in Children with Incident Systemic Lupus Erythematosus.
            Pediatr Cardiol. 2019 Apr 30. doi: 10.1007/s00246-019-02107-1. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/31041461
          • Abdelrahman N, Beresford MW, Leone V; UK Juvenile-onset Systemic Lupus Erythematosus Study Group.
            Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients.
            Lupus. 2019 Apr 3:961203319840699. doi: 10.1177/0961203319840699. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30943853
 
MARZO 2019
          • Carreira PL, Isenberg DA
            Recent developments in biologic therapies for the treatment of patients with systemic lupus erythematosus
            Rheumatology (Oxford) 2019 Mar; 58(3):382-387
            https://doi.org/10.1093/rheumatology/key064
          • Smith E, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley D, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan A, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM
            Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
            Lupus. 2019 Mar 14:961203319836712. doi: 10.1177/0961203319836712. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30871425
          • Kronbichler A, Brezina B, Gauckler P, Quintana LF, Jayne DRW.
            Refractory lupus nephritis: When, why and how to treat.
            Autoimmun Rev. 2019 Mar 4. pii: S1568-9972(19)30057-6. doi: 10.1016/j.autrev.2019.03.004. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30844548
          • Zhong Z, Li H, Zhong H, Zhou T.
            Clinical efficacy and safety of rituximab in lupus nephritis.
            Drug Des Devel Ther. 2019 Mar 11;13:845-856
            https://www.ncbi.nlm.nih.gov/pubmed/30880917
          • Jesus D, Matos A, Henriques C, Zen M, Larosa M, Iaccarino L, Pereira Da Silva JÁ, Doria A, Sousa Inês L
            Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity
            Ann Rheum Dis 2019 Mar; 78:365-371
            https://ard.bmj.com/content/78/3/365
          • Urowitz MB, Ohsfeldt RL, Wielage RC, Kelton KA, Asukai Y, Ramachandran S
            Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis
            Ann Rheum Dis 2019 Mar; 78(3):372-379
            https://ard.bmj.com/content/78/3/372
          • Kwan A, Marzouk S, Ghanean H, Kishwar A, Anderson N, Bonilla D, Vitti M, Su J, Touma Z.
            Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus.
            Semin Arthritis Rheum. 2019 Mar 9. pii: S0049-0172(18)30773-X. doi: 10.1016/j.semarthrit.2019.03.004. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30940467
          • Kim AHJ, Strand V, Sen DP, Fu Q, Mathis NL, Schmidt MJ, Bruchas RR, Staten NR, Olson PK, Stiening CM, Atkinson JP.
            Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
            Arthritis Rheumatol. 2019 Mar;71(3):420-430
            https://www.ncbi.nlm.nih.gov/pubmed/30294950

          • Briand C, Frémond M, Bessis D, Carbasse A, Rice GI, Bondet Vincent, Duffy D, Chatenoud L, Blanche S, Crow YJ, Neven B
            Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency.
            Ann Rheum Dis 2019 Mar;78(3):431-433.
            https://ard.bmj.com/content/78/3/431
 
FEBRERO 2019
          • Yeung KS, Lee TL, Mok MY, Mak CCY, Yang W, Chong PCY, Lee PPW, Ho MHK, Choufani S, Lau CS, Lau YL, Weksberg R, Chung BHY.
            Cell Lineage-specific Genome-wide DNA Methylation Analysis of Patients with Paediatric-onset Systemic Lupus Erythematosus.
            Epigenetics. 2019 Feb 26. doi: 10.1080/15592294.2019.1585176.
            https://www.ncbi.nlm.nih.gov/pubmed/30806140
          • Kim H, Levy DM, Silverman ED, Hitchon C, Bernatsky S, Pineau C, Smith CD, Tucker L, Petty R, Arbillaga H, Zummer M, Hudson M, Fortin P, Huber AM, Chedeville G, Peschken C, Pope JE.
            A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort.
            Rheumatology (Oxford). 2019 Feb 25. pii: kez006. doi: 10.1093/rheumatology/kez006. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30805629
          • Arkin L, Buhr K, Brandling-Bennett H, Chiu Y, Chong B, Curran M, Hunt R, Paller AS, Werth V, Klein-Gitelman M, von Scheven E, Ardalan K.
            Practice-Based Differences in Pediatric Discoid Lupus Erythematosus.
            Br J Dermatol. 2019 Feb 15. doi: 10.1111/bjd.17780. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30768778
          • Inoue M, Kawamura M, Yamamoto H, Takahashi T, Kihara S.
            Juvenile-onset systemic lupus erythematosus with severe hypertriglyceridemia induced by anti-apolipoprotein C-II antibody.
            Pediatr Int. 2019 Feb;61(2):201-203. doi: 10.1111/ped.13736. Epub 2019 Jan 31.
            https://www.ncbi.nlm.nih.gov/pubmed/30706594
 
ENERO 2019
          • Brunner HI, Holland MJ, Beresford MW, Ardoin SP, Appenzeller S, Silva CA, Flores F, Goilav B, Avar Aydin PO, Wenderfer SE, Levy DM, Ravelli A, Khubchandani R, Avcin T, Klein-Gitelman MS, Ruperto N, Feldman BM, Ying J; Paediatric Rheumatology International Trial Organisation & the Pediatric Rheumatology Collaborative Study Group.
            The American College of Rheumatology Provisional criteria for clinically relevant improvement in children & adolescents with childhood-onset systemic lupus erythematosus.
            Arthritis Care Res (Hoboken). 2019 Jan 25. doi: 10.1002/acr.23834. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30680946
          • Hammenfors DS, Valim V, Bica BERG, Pasoto SG, Lilleby V, Nieto-González JC, Silva CA, Mossel E, Pereira RMR, Coelho A4, Bootsma H, Thatayatikom A, Brun JG, Jonsson MV.
            Juvenile Sjögren's syndrome: clinical characteristics with focus on salivary gland ultrasonography.
            Arthritis Care Res (Hoboken). 2019 Jan 30. doi: 10.1002/acr.23839. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30697959
 
DICIEMBRE 2018
          • Osaku FM, Fraga MM, Aires PP, Caparroz AA, Len CA, Terreri MT
            SLICC classification criteria for juvenile systemic lupus erythematosus: a cross sectional study.
            Acta Reumatol Port. 2018 Oct-Dec;43(4):279-283.
            https://www.ncbi.nlm.nih.gov/pubmed/30641536
 
NOVIEMBRE 2018
          • Jia E, Geng H, Liu Q, Xiao Y, Zhang Y, Xie J, Zhang L, Qiu X, Zhong L, Xiao M, Zhang J
            Cardiac manifestations of Han Chinese patients with systemic lupus erythematosus: a retrospective study.
            Ir J Med Sci. 2018 Nov 20. doi: 10.1007/s11845-018-1934-7. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30460452
 
OCTUBRE 2018
          • Garg M, Mufti N, Palmore TN, Hasni SA.
            Recommendations and barriers to vaccination in systemic lupus erythematosus.
            Autoimmun Rev. 2018 Oct;17(10):990-1001.
            https://www.ncbi.nlm.nih.gov/pubmed/30103044
          • Hui-Yuen JS, Gartshteyn Y, Ma M, O'Malley T, Conklin J, Eichenfield AH, Imundo LF, Dervieux T, Askanase AD.
            Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity.
            Lupus. 2018 Oct 30:961203318809181. doi: 10.1177/0961203318809181. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30376789
          • Cooper JC, Rouster-Stevens K, Wright TB, Hsu JJ, Klein-Gitelman MS, Ardoin SP, Schanberg LE, Brunner HI, Eberhard BA, Wagner-Weiner L, Mehta J, Haines K, McCurdy DK, Phillips TA, Huang Z, von Scheven E; CARRA registry investigators.
            Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis.
            Pediatr Rheumatol Online J. 2018 Oct 22;16(1):65. doi: 10.1186/s12969-018-0279-0.
            https://www.ncbi.nlm.nih.gov/pubmed/30348175
          • Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, De Uña-Álvarez J, Balboa-Barreiro V, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Mouriño-Rodríguez C, Horcada L, Sánchez-Atrio A, Montilla C, Salgado E, Díez-Álvarez E, Blanco R, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JA, Gantes M, Hernández-Cruz B, Pecondón-Español A, Marras C, Bonilla G, Pego-Reigosa JM; RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER).
            Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).
            Semin Arthritis Rheum. 2018 Sep 27. pii: S0049-0172(18)30339-1. doi: 10.1016/j.semarthrit.2018.09.005. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30344081
 
SEPTIEMBRE 2018
          • Paule R, Morel N, Le Guern V, Fredi M, Coutte L, Belhocine M, Mouthon L, le Jeunne C, Chauvin A, Piette JC, Costedoat-Chalumeau N.
            Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients.
            Autoimmun Rev. 2018 Sep;17(9):866-872
            https://www.ncbi.nlm.nih.gov/pubmed/30005859
          • Gao H, Wang Q, Yu X, Liu J, Bai S, Feng J, Wu B.
            Molecular mechanisms of glucocorticoid resistance in systemic lupus erythematosus: A review.
            Life Sci. 2018 Sep 15;209:383-387
            https://www.ncbi.nlm.nih.gov/pubmed/30125579
          • Vaglio A, Grayson PC, Fenaroli P, Gianfreda D, Boccaletti V, Ghiggeri GM, Moroni G.
            Drug-induced lupus: Traditional and new concepts.
            Autoimmun Rev. 2018 Sep;17(9):912-918.
            https://www.ncbi.nlm.nih.gov/pubmed/30005854
 
AGOSTO 2018
          • Krzeminski P, Lesiak A, Narbutt J.
            Seizures as a rare adverse effect of chloroquine therapy in systemic lupus erythematosus patients: a case report and literature survey.
            Postepy Dermatol Alergol. 2018 Aug;35(4):429-430. doi: 10.5114/ada.2018.77675. Epub 2018 Aug 21.
            https://www.ncbi.nlm.nih.gov/pubmed/30206460
          • Brunner HI, Gulati G, Klein-Gitelman MS, Rouster-Stevens KA, Tucker L, Ardoin SP, Onel KB, Mainville R, Turnier J, Aydin POA, Witte D, Huang B11, Bennett MR, Devarajan P.
            Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
            Pediatr Nephrol. 2018 Aug 29. doi: 10.1007/s00467-018-4049-5. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30159624
          • Groot N, Shaikhani D, Teng YKO, de Leeuw K, Bijl M, Dolhain RJEM, Zirkzee E, Fritsch-Stork R, Bultink IEM, Kamphuis S1.
            Long-term clinical outcomes in a cohort of adults with childhood-onset Systemic Lupus Erythematosus.
            Arthritis Rheumatol. 2018 Aug 27. doi: 10.1002/art.40697. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30152151
          • Chiang YC, Huang JL, Wang CH, Lee HC, Lee MY, Hsiao YC.
            Symptom clustering in patients with childhood-onset systemic lupus erythematosus.
            J Adv Nurs. 2018 Aug 14. doi: 10.1111/jan.13825. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30109714
          • Pilania RK, Suri D, Jindal AK, Kumar N, Sharma A, Sharma P, Guleria S, Rawat A, Ahluwalia J, Singh S.
            Lupus anticoagulant hypoprothrombinemia syndrome associated with systemic lupus erythematosus in children: report of two cases and systematic review of the literature.
            Rheumatol Int. 2018 Oct;38(10):1933-1940. doi: 10.1007/s00296-018-4127-9. Epub 2018 Aug 11.
            https://www.ncbi.nlm.nih.gov/pubmed/30099593
          • Shoaib RMS, Hammad A, Yahia S, Elsaid A, Abdel-Malak CA.
            Angiotensin II type 1 receptor gene polymorphism and serum angiotensin-converting enzyme level in Egyptian children with systemic lupus erythematosus.
            Clin Rheumatol. 2018 Aug 9. doi: 10.1007/s10067-018-4255-3. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30094750
          • Ferreira JCOA, Trindade VC, Espada G, Morel Z, Bonfá E, Magalhães CS, Silva CA.
            Epidemiology and management practices for childhood-onset systemic lupus erythematosus patients: a survey in Latin America.
            Clin Rheumatol. 2018 Aug 9. doi: 10.1007/s10067-018-4254-4. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30094748
          • Aggarwal A, Phatak S, Srivastava P, Lawrence A, Agarwal V, Misra R.
            Outcomes in juvenile onset lupus: single center cohort from a developing country.
            Lupus. 2018 Aug 2:961203318791046. doi: 10.1177/0961203318791046. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30071768
 
JULIO 2018
          • Chang JC, Knight AM, Xiao R, Mercer-Rosa LM, Weiss PF.
            Use of echocardiography at diagnosis and detection of acute cardiac disease in youth with systemic lupus erythematosus.
            Lupus. 2018 Jul;27(8):1348-1357. doi: 10.1177/0961203318772022. Epub 2018 Apr 24.
            https://www.ncbi.nlm.nih.gov/pubmed/29688145
          • Davis AM,Graham TB, Zhu Y, McPheeters ML.
            Depression and medication nonadherence in childhood-onset systemic lupus erythematosus.
            Lupus.2018 Aug;27(9):1532-1541. doi: 10.1177/0961203318779710. Epub 2018 Jun 28.
            https://www.ncbi.nlm.nih.gov/pubmed/29954282
          • Hassan AM, Farghal NMA, Hegab DS, Mohamed WS, Abd-Elnabi HH.
            Serum-soluble CXCL16 in juvenile systemic lupus erythematosus: a promising predictor of disease severity and lupus nephritis.
            Clin Rheumatol. 2018 Jul 13. doi: 10.1007/s10067-018-4203-2. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30006918
          • Brunner HI, Holland M, Beresford MW, Ardoin SP, Appenzeller S, Silva CA, Flores F, Goilav B, Wenderfer SE, Levy DM, Ravelli A, Khunchandani R, Avcin T, Klein-Gitelman MS, Feldman BM, Ruperto N, Ying J; PRCSG and PRINTO Investigators.
            American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus.
            Arthritis Care Res (Hoboken). 2018 Jun;70(6):813-822. doi: 10.1002/acr.23557. Epub 2018 Apr 25.
            https://www.ncbi.nlm.nih.gov/pubmed/29693328
          • Batu ED, Koşukcu C, Taşkıran E, Sahin S, Akman S, Sözeri B, Ünsal E, Bilginer Y, Kasapcopur O, Alikaşifoğlu M, Ozen S.
            Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus.
            J Rheumatol. 2018 Jul 15. pii: jrheum.171358. doi: 10.3899/jrheum.171358. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/30008451
 
JUNIO 2018
          • Tekin ZE, Yener GO, Yüksel S.
            Acquired angioedema in juvenile systemic lupus erythematosus: case-based review.
            Rheumatol Int. 2018 Jun 27. doi: 10.1007/s00296-018-4088-z
            https://www.ncbi.nlm.nih.gov/pubmed/29951963
          • Pisetsky DS.
            Role of Epstein-Barr virus infection in SLE: gene-environment interactions at the molecular level.
            Ann Rheum Dis. 2018 Jun 1. pii: annrheumdis-2018-213783. doi: 10.1136/annrheumdis-2018-213783
            https://www.ncbi.nlm.nih.gov/pubmed/29858172
          • Abad TO, Sarni RO, da Silva SG, Machado D, Suano-Souza FI, Len CA, Terreri MT.
            Nutritional intervention in patients with juvenile systemic lupus erythematosus: protective effect against the increase in fat mass.
            Rheumatol Int. 2018 Jun;38(6):985-992. doi: 10.1007/s00296-018-4031-3
            https://www.ncbi.nlm.nih.gov/pubmed/29721693
 
MAYO 2018
          • Abdel-Nabi HH, Abdel-Noor RA.
            Comparison between disease onset patterns of Egyptian juvenile and adult systemic lupus erythematosus (single centre experience).
            Lupus. 2018 May;27(6):1039-1044. doi: 10.1177/0961203318760208. Epub 2018 Feb 20.
            https://www.ncbi.nlm.nih.gov/pubmed/29460702
          • Lim LSH, Pullenayegum E, Feldman BM, Lim L, Gladman DD, Silverman ED.
            From Childhood to Adulthood: Disease Activity Trajectories in Childhood-Onset Systemic Lupus Erythematosus.
            Arthritis Care Res (Hoboken). 2018 May;70(5):750-757. doi: 10.1002/acr.23319. Epub 2018 Mar 25.
            https://www.ncbi.nlm.nih.gov/pubmed/28704581
          • Julià A, López-Longo FJ, Pérez Venegas JJ, Bonàs-Guarch S, Olivé À, Andreu JL, Aguirre-Zamorano MÁ, Vela P, Nolla JM, de la Fuente JLM, Zea A, Pego-Reigosa JM, Freire M, Díez E, Rodríguez-Almaraz E, Carreira P, Blanco R, Taboada VM, López-Lasanta M, Corbeto ML, Mercader JM, Torrents D, Absher D, Marsal S, Fernández-Nebro A.
            Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus.
            Arthritis Res Ther. 2018 May 30;20(1):100. doi: 10.1186/s13075-018-1604-1.
            https://www.ncbi.nlm.nih.gov/pubmed/29848360
          • Fonseca R, Aguiar F, Rodrigues M, Brito I.
            Clinical phenotype and outcome in lupus according to age: a comparison between juvenile and adult onset.
            Reumatol Clin. 2018 May - Jun;14(3):160-163. doi: 10.1016/j.reuma.2016.10.011. Epub 2016 Dec 28. English, Spanish.
            https://www.ncbi.nlm.nih.gov/pubmed/28040420
 
ABRIL 2018
          • Abdel-Nabi HH, Abdel-Noor RA.
            Comparison between disease onset patterns of Egyptian juvenile and adult systemic lupus erythematosus (single centre experience).
            Lupus.2018 May;27(6):1039-1044. doi: 10.1177/0961203318760208. Epub 2018 Feb 20.
            https://www.ncbi.nlm.nih.gov/pubmed/29460702
          • El Hadidi KT, Medhat BM, Abdel Baki NM, Abdel Kafy H, Abdelrahaman W, Yousri AY, Attia DH, Eissa M, El Dessouki D, Elgazzar I, Elgengehy FT, El Ghobashy N, El Hadary H, El Mardenly G, El Naggar H, El Nahas AM, El Refai RM, El Rwiny HA, Elsman RM, Galal M, Ghoniem S, Maged LA, Sally SM, Naji H, Saad S, Shaaban M, Sharaf M, Sobhy N, Soliman RM, El Hadidi TS.
            Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center.
            Lupus. 2018 May;27(6):1030-1038. doi: 10.1177/0961203317751856. Epub 2018 Feb 10.
            https://www.ncbi.nlm.nih.gov/pubmed/29431056
          • da Silva SGL, Terreri MT, Abad TTO, Machado D, Fonseca FLA, Hix S, Suano-Souza FI, Sarni ROS, Len CA.
            The effect of nutritional intervention on the lipid profile and dietary intake of adolescents with juvenile systemic lupus erythematosus: a randomized, controlled trial.
            Lupus. 2018 Apr;27(5):820-827. doi: 10.1177/0961203317751851. Epub 2018 Jan 10.
            https://www.ncbi.nlm.nih.gov/pubmed/29320971
 
MARZO 2018
          • Wang R, Zeng YL, Qin HM, Lu YL, Huang HT, Lei M, Tan T, Huang YY, Luo HC, Lan Y, Wei YS.
            Association of interleukin 22 gene polymorphisms and serum IL-22 level with risk of systemic lupus erythematosus in a Chinese population.
            Clin Exp Immunol. 2018 Mar 30. doi: 10.1111/cei.13133. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/29603203
          • Athanasopoulos E, Kalaitzidou I, Vlachaki G, Stefanaki S, Tzagkaraki A, Niotakis G, Tritou I, Ladomenou F.
            Chorea revealing systemic lupus erythematosus in a 13-year old boy: A case report and short review of the literature.
            Int Rev Immunol. 2018 Mar 29:1-6. doi: 10.1080/08830185.2018.1452920. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/29595356
          • Bortoluzzi A, Scirè CA, Govoni M.
            Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus.
            Front Med (Lausanne). 2018 Mar 14;5:68. doi: 10.3389/fmed.2018.00068.
            https://www.ncbi.nlm.nih.gov/pubmed/29594125
 
FEBRERO 2018
          • Holland MJ, Beresford MW, Feldman BM, Huggins J, Norambuena X, Silva CA, Susic G, Sztajnbok F, Uziel Y, Appenzeller S, Ardoin SP, Avcin T, Flores F, Goilav B, Khubchandani R, Klein-Gitelman M, Levy D, Ravelli A, Wenderfer SE, Ying J, Ruperto N, Brunner HI; PRINTO PRCSG Investigators.
            Measuring Disease Damage and its Severity in Childhood-Onset Systemic Lupus Erythematosus
            Arthritis Care Res (Hoboken). 2018 Feb 6. doi: 10.1002/acr.23531.
            https://www.ncbi.nlm.nih.gov/pubmed/29409150
          • Smith EMD, Yin P, Jorgensen AL, Beresford MW; UK JSLE Study Group
            Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study
            Pediatr Rheumatol Online J. 2018 Feb 21;16(1):14. doi: 10.1186/s12969-018-0230-4.
            https://www.ncbi.nlm.nih.gov/pubmed/29467038
 
ENERO 2018
          •  da Silva SGL, Terreri MT, Abad TTO, Machado D, Fonseca FLA, Hix S, Suano-Souza FI, Sarni ROS, Len CA. The effect of nutritional intervention on the lipid profile and dietary intake of adolescents with juvenile systemic lupus erythematosus: a randomized, controlled trial.
            Lupus. 2018 Jan 1:961203317751851. doi: 10.1177/0961203317751851. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/29320971
          • Cetin Gedik K, Siddique S, Aguiar CL.
            Rituximab use in pediatric lupus anticoagulant hypoprothrombinemia syndrome - report of three cases and review of the literature.
            Lupus. 2018 Jan 1:961203317751853. doi: 10.1177/0961203317751853. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/29320972
          • Hartman EAR, van Royen-Kerkhof A, Jacobs JWG, Welsing PMJ, Fritsch-Stork RDE.
            Performance of the 2012 Systemic Lupus International Collaborating Clinics classification criteria versus the 1997 American College of Rheumatology classification criteria in adult and juvenile systemic lupus erythematosus. A systematic review and meta-analysis.
            Autoimmun Rev. 2018 Jan 31. pii: S1568-9972(18)30015-6. doi: 10.1016/j.autrev.2018.01.007. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/29366725
 
DICIEMBRE 2017
          • Tian SY, Silverman ED, Pullenayegum E, Brown PE, Beyene J, Feldman BM.
            Comparative Effectiveness of Mycophenolate Mofetil for the Treatment of Juvenile-Onset Proliferative Lupus Nephritis.
            Arthritis Care Res (Hoboken). 2017 Dec;69(12):1887-1894.
            https://www.ncbi.nlm.nih.gov/pubmed/28182833
          • Tektonidou MG1, Lewandowski LB2, Hu J2, Dasgupta A2, Ward MM2.
            Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016.
            Ann Rheum Dis. 2017 Dec;76(12):2009-2016.
            https://www.ncbi.nlm.nih.gov/pubmed/28794077
          • Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Özen S, Pilkington CA, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert BJ, Wulffraat NM, Beresford MW, Kamphuis S.
            European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.
            Ann Rheum Dis. 2017 Dec;76(12):1965-1973. doi: 10.1136/annrheumdis-2017-211898. Epub 2017 Sep 6.
            https://www.ncbi.nlm.nih.gov/pubmed/28877866
          • Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, Sánchez-Alonso F, López-Longo FJ, Galindo-Izquierdo M, et al. RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER).
            Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).
            Clin Exp Rheumatol. 2017 Nov-Dec;35(6):1047-1055.
            https://www.ncbi.nlm.nih.gov/pubmed/28628467
          • Wen L, Zhu C, Zhu Z, Yang C, Zheng X, Liu L, Zuo X, Sheng Y, Tang H, Liang B, Zhou Y, Li P, Zhu J, Ding Y, Chen G, Gao J, Tang L, Cheng Y, Sun J, Elango T, Kafle A, Yu R, Xue K, Zhang Y, Li F, Li Z, Guo J, Zhang X, Zhou C, Tang Y, Shen N, Wang M, Yu X, Liu S, Fan X, Gao M, Xiao F, Wang P, Wang Z, Zhang A, Zhou F, Sun L, Yang S, Xu J, Yin X, Cui Y, Zhang X.
            Exome-wide association study identifies four novel loci for systemic lupus erythematosus in Han Chinese population.
            Ann Rheum Dis. 2017 Dec 12. pii: annrheumdis-2017-211823. doi: 10.1136/annrheumdis-2017-211823. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29233832
          • Stojan G, Petri M.
            Epidemiology of systemic lupus erythematosus: an update.
            Curr Opin Rheumatol. 2017 Dec 14. doi: 10.1097/BOR.0000000000000480. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/29251660
          • Fasano S, Margiotta DP, Navarini L, Pierro L, Pantano I, Riccardi A, Afeltra A, Valentini G.
            Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.
            Lupus. 2017 Dec;26(14):1463-1472.
            https://www.ncbi.nlm.nih.gov/pubmed/28786768
          • Chatham W, Chadha A, Fettiplace J, Kleoudis C, Bass D, Roth D, Gordon D.
            A randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus.
            Lupus. 2017 Dec;26(14):1483-1490.
            https://www.ncbi.nlm.nih.gov/pubmed/28467293
          • Restrepo-Escobar M, Granda-Carvajal PA, Jaimes F.
            Systematic review of the literature on reproducibility of the interpretation of renal biopsy in lupus nephritis.
            Lupus. 2017 Dec;26(14):1502-1512.
            https://www.ncbi.nlm.nih.gov/pubmed/28441914
          • Vanoni F, Lava SAG, Fossali EF, Cavalli R, Simonetti GD, Bianchetti MG, Bozzini MA, Agostoni C, Milani GP.
            Neonatal Systemic Lupus Erythematosus Syndrome: a Comprehensive Review.
            Clin Rev Allergy Immunol. 2017 Dec;53(3):469-476. doi: 10.1007/s12016-017-8653-0. Review.
            https://www.ncbi.nlm.nih.gov/pubmed/29116459
 
NOVIEMBRE 2017
          • Alves AGF, de Azevedo Giacomin MF, Braga ALF, Sallum AME, Pereira LAA, Farhat LC, Strufaldi FL, de Faria Coimbra Lichtenfels AJ, de Santana Carvalho T, Nakagawa NK, Silva CA, Farhat SCL.
            Influence of air pollution on airway inflammation and disease activity in childhood-systemic lupus erythematosus.
            Clin Rheumatol. 2017 Nov 2
            https://www.ncbi.nlm.nih.gov/pubmed/29098476
          • Lima GL, Paupitz JA, Aikawa NE, Alvarenga JC, Pereira RMR.
            A randomized double-blind placebo-controlled trial of vitamin D supplementation in juvenile-onset systemic lupus erythematosus: positive effect on trabecular microarchitecture using HR-pQCT.
            Osteoporos Int. 2017 Nov 19
            https://www.ncbi.nlm.nih.gov/pubmed/29152675
          • Lim LSH, Pullenayegum E, Lim L, Gladman D, Feldman B, Silverman E.
            From Childhood to Adulthood: The Trajectory of Damage in Patients With Juvenile-Onset Systemic Lupus Erythematosus.
            Arthritis Care Res (Hoboken). 2017 Nov;69(11):1627-1635
            https://www.ncbi.nlm.nih.gov/pubmed/28118527
 
OCTUBRE 2017
          • Cavalcanti A, Almeida R, Mesquita Z, Duarte ALBP, Donadi EA, Lucena-Silva N.
            Gene polymorphism and HLA-G expression in patients with childhood-onset systemic lupus erythematosus: A pilot study.
            HLA. 2017 Oct;90(4):219-227. doi: 10.1111/tan.13084.
            https://www.ncbi.nlm.nih.gov/pubmed/28695673
          • Bennett MR, Ma Q, Ying J, Devarajan P, Brunner H.
            Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL).
            Pediatr Rheumatol Online J. 2017 Oct 13;15(1):74. doi: 10.1186/s12969-017-0202-0.
            https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29029629
          • Turnier JL, Fall N, Thornton S, Witte D, Bennett MR, Appenzeller S, Klein-Gitelman MS, Grom AA, Brunner HI.
            Urine S100 proteins as potential biomarkers of lupus nephritis activity
            Arthritis Res Ther. 2017 Oct 24;19(1):242. doi: 10.1186/s13075-017-1444-4.
            https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29065913
 
SEPTIEMBRE 2017
          • Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Özen S, Pilkington CA, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert BJ, Wulffraat NM, Beresford MW, Kamphuis S.
            European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.
            Ann Rheum Dis. 2017 Sep 6. pii: annrheumdis-2017-211898. doi: 10.1136/annrheumdis-2017-211898. [Epub ahead of print].
            https://www.ncbi.nlm.nih.gov/pubmed/28877866
          • Bundhun PK, Kumari A, Huang F.
            Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: A systematic review and meta-analysis.
            Medicine (Baltimore). 2017 Sep;96(37):e8086. doi: 10.1097/MD.0000000000008086.
            https://www.ncbi.nlm.nih.gov/pubmed/28906413
          • Kisla Ekinci RM, Balci S, Bisgin A, Altintas DU, Yilmaz M.
            A homozygote TREX1 mutation in two siblings with different phenotypes: Chilblains and cerebral vasculitis.
            Eur J Med Genet. 2017 Sep 13. pii: S1769-7212(17)30362-2. doi: 10.1016/j.ejmg.2017.09.004. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28919362
          • Sahin S, Adrovic A, Barut K, Durmus S, Gelisgen R, Uzun H, Kasapcopur O.
            Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus.
            Lupus. 2017 Sep;26(10):1089-1094.
            https://www.ncbi.nlm.nih.gov/pubmed/28420068
 
JULIO 2017
          • Lim LSH, Pullenayegum E, Feldman BM, Lim L, Gladman DD, Silverman ED.
            From Childhood to Adulthood: Disease Activity Trajectories in Childhood-Onset Systemic Lupus Erythematosus.
            Arthritis Care Res (Hoboken). 2017 Jul 13. doi: 10.1002/acr.23319. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28704581
          • Groot N, Graeff N, Avcin T, Bader-Meunier B, Brogan P, Dolezalova P, Feldman B, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Ozen S, Pilkington C, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW.
            European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative.
            Ann Rheum Dis. 2017 Jun 19. pii: annrheumdis-2016-210960. doi: 10.1136/annrheumdis-2016-210960. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28630236
          • Brunner HI, Bennett MR, Gulati G, Abulaban K, Klein-Gitelman MS, Ardoin SP, Tucker LB, Rouster-Stevens KA, Witte D, Ying J, Devarajan P.
            Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults.
            J Rheumatol. 2017 Aug;44(8):1239-1248. doi: 10.3899/jrheum.161128. Epub 2017 Jun 15.
            https://www.ncbi.nlm.nih.gov/pubmed/28620062
          • Su-Angka N, Khositseth A, Vilaiyuk S, Tangnararatchakit K, Prangwatanagul W.
            Carotid intima-media thickness and arterial stiffness in pediatric systemic lupus erythematosus.
            Lupus. 2017 Aug;26(9):989-995. doi: 10.1177/0961203317692434. Epub 2017 Jan 1.
            https://www.ncbi.nlm.nih.gov/pubmed/28420050
 
JUNIO 2017
          • Segal Y, Calabrò M, Kanduc D, Shoenfeld Y.
            Human papilloma virus and lupus: the virus, the vaccine and the disease.
            Curr Opin Rheumatol. 2017 Jul;29(4):331-342.
            https://www.ncbi.nlm.nih.gov/pubmed/28394823
          • Neuman H, Koren O.
            The gut microbiota: a possible factor influencing systemic lupus erythematosus.
            Curr Opin Rheumatol. 2017 Jul;29(4):374-377.
            https://www.ncbi.nlm.nih.gov/pubmed/28376066
          • Ulff-Møller CJ, Simonsen J, Kyvik KO, Jacobsen S, Frisch M.
            Family history of systemic lupus erythematosus and risk of autoimmune disease: Nationwide Cohort Study in Denmark 1977-2013.
            Rheumatology (Oxford). 2017 Jun 1;56(6):957-964.
            https://www.ncbi.nlm.nih.gov/pubmed/28339674
          • Touma Z, Sayani A, Pineau CA, Fortin I, Matsos M, Ecker GA, Chow A, Iczkovitz S.
            Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study.
            Rheumatol Int. 2017 Jun;37(6):865-873.
            https://www.ncbi.nlm.nih.gov/pubmed/28280970
          • Kang JH, Park DJ, Lee KE, Lee JS, Choi YD, Lee SS.
            Comparison of clinical, serological, and prognostic differences among juvenile-, adult-, and late-onset lupus nephritis in Korean patients.
            Clin Rheumatol. 2017 Jun;36(6):1289-1295.
            https://www.ncbi.nlm.nih.gov/pubmed/28444577
          • Groot N, Graeff N, Avcin T, Bader-Meunier B, Brogan P, Dolezalova P, Feldman B, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Ozen S, Pilkington C, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW.
            European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative.
            Ann Rheum Dis. 2017 Jun 19 doi: 10.1136/annrheumdis-2016-210960.
            https://www.ncbi.nlm.nih.gov/pubmed/28630236
          • Reddy V, Martinez L, Isenberg DA, Leandro MJ, Cambridge G.
            Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins.
            Arthritis Care Res (Hoboken). 2017 Jun;69(6):857-866.
            https://www.ncbi.nlm.nih.gov/pubmed/27428176
          • Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, Sánchez-Alonso F, López-Longo FJ, Galindo-Izquierdo M, et al.
            Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).
            Clin Exp Rheumatol. 2017 Jun 12. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28628467
 
MAYO 2017
          • Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman B, Kenet G, Koné-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington CA, Ravelli A, van Royen-Kerkhof A, Uziel Y, Vastert SJ, Wulffraat NM, Ozen S, Brogan P, Kamphuis S, Beresford MW.
            European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative.
            Ann Rheum Dis. 2017 May 4. pii: annrheumdis-2016-211001. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28473426
          • Dall'Era M.
            Treatment of lupus nephritis: current paradigms and emerging strategies.
            Curr Opin Rheumatol. 2017 May;29(3):241-247. doi:10.1097/BOR.0000000000000381.
            https://www.ncbi.nlm.nih.gov/pubmed/28207493
          • Vreede AP, Bockenstedt PL, Knight JS.
            Antiphospholipid syndrome: an update for clinicians and scientists.
            Curr Opin Rheumatol. 2017 May 22. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28538012
          • Izmirly P, Saxena A, Buyon
            Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus.
            Curr Opin Rheumatol. 2017 May 16. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28520682
          • Chen L, Morris DL, Vyse TJ.
            Genetic advances in systemic lupus erythematosus: an update.
            Curr Opin Rheumatol. 2017 May 15. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28509669
          • Bundhun PK, Soogund MZ, Huang F
            Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: A meta-analysis of studies published between years 2001-2016.
            J Autoimmun. 2017 May;79:17-27. doi: 10.1016/j.jaut.2017.02.009
            https://www.ncbi.nlm.nih.gov/pubmed/?term=28256367
          • Artim-Esen B, Şahin S, Çene E, Şahinkaya Y, Barut K, Adrovic A, Özlük Y, Kılıçaslan I, Omma A, Gül A, Öcal L, Kasapçopur Ö, İnanç M.
            Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey.
            J Rheumatol. 2017 May;44(5):619-625. doi: 10.3899/jrheum.160340.
            https://www.ncbi.nlm.nih.gov/pubmed/?term=28298568
          • Wu EY, Schanberg LE, Wershba EC, Rabinovich CE.
            Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus.
            Lupus. 2017 May;26(6):646-649. doi: 10.1177/0961203316676377.
            https://www.ncbi.nlm.nih.gov/pubmed/?term=27837194
 
ABRIL 2017
          • Sinicato NA, Postal M, de Oliveira Peliçari K, Rittner L, Marini R, Appenzeller S.
            Prevalence and features of metabolic syndrome in childhood-onset systemic lupus erythematosus
            Clin Rheumatol. 2017 Apr 19. doi: 10.1007/s10067-017-3602-0. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28424906
          • Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau FA, Jourde-Chiche N, Koné-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin-Silva N, Martin T, Maurier F, Meckenstock R, Mékinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi-Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg JE.
            International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus
            Autoimmun Rev. 2017 Apr 18. pii: S1568-9972(17)30108-8. doi: 10.1016/j.autrev.2017.04.011. [Epub ahead of print] Review.
            https://www.ncbi.nlm.nih.gov/pubmed/28434948
          • Zuppa AA, Riccardi R, Frezza S, Gallini F, Luciano RM, Alighieri G, Romagnoli C, De Carolis S.
            Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature
            Autoimmun Rev. 2017 Apr;16(4):427-432. doi: 10.1016/j.autrev.2017.02.010. Epub 2017 Feb 14. Review.
            https://www.ncbi.nlm.nih.gov/pubmed/28212920
MARZO 2017
          • Yokogawa N, Eto H, Tanikawa A, Ikeda T, Yamamoto K, Takahashi T, Mizukami H, Sato T, Yokota N, Furukawa F.
            Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus: A Multicenter, Double-Blind, Randomized, Parallel-Group Trial
            Arthritis Rheumatol 2017 Apr;69(4):791-9 DOI: 10.1002/art.40018.
            http://onlinelibrary.wiley.com/doi/10.1002/art.40018/full
          • Stohl W, Schwarting A, Okada M, Scheinberg M, Doria A, Hammer AE, Kleoudis C, Groark J, Bass D, Fox NL, Roth D, Gordon D.
            Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two–Week Randomized, Double-Blind, Placebo-Controlled Study
            Arthritis Rheumatol 7 Apr 2017 DOI: 10.1002/art.40049 Epub ahead of print.
            http://onlinelibrary.wiley.com/doi/10.1002/art.40049/abstract
          • Isenberg D, Sturgess J, Allen E, Aranow C, Askanase A, Sang-Cheol B, Bernatsky S, Bruce I, Buyon J, Cervera R, Clarke A, Dooley MA, Fortin P, Ginzler E, Gladman D, Hanly J, Inanc M, Jacobsen S, Kamen D, Khamashta M, Lim S, Manzi S, Nived O, Peschken C, Petri M, Kalunian K, Rahman A, Ramsey-Goldman R, Ruiz-Irastorza G, Sanchez-Guerrero J, Steinsson K, Sturfelt G, Urowitz M, van Vollenhoven R, Wallace DJ, Zoma A, Merrill J, Gordon C.
            A study of flare assessment in systemic lupus erythematosus (SLE) based on paper patients.
            Arthritis Care Res (Hoboken). 2017 Apr 7. doi: 10.1002/acr.23252. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28388813
          • Liphaus BL, Kiss MH, Carrasco S, Palmeira P, Goldenstein-Schainberg C, Carneiro-Sampaio M.
            Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
            Clin Rheumatol. 2017 Apr 4. doi: 10.1007/s10067-017-3615-8. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28378099
          • Ahn SS, Yoo BW, Jung SM, Lee SW, Park YB, Song JJ.
            In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome.
            Semin Arthritis Rheum. 2017 Feb 8. pii: S0049-0172(16)30373-0. doi: 10.1016/j.semarthrit.2017.02.002. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28268026
          • Lythgoe H, Morgan T, Heaf E, Lloyd O, Al-Abadi E, Armon K, Bailey K, Davidson J, Friswell M, Gardner-Medwin J, Haslam K, Ioannou Y, Leahy A, Leone V, Pilkington C, Rangaraj S, Riley P, Tizard EJ, Wilkinson N, Beresford MW; UK JSLE Study Group..
            Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis.
            Lupus. 2017 Jan 1:961203317700484. doi: 10.1177/0961203317700484. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28361566
FEBRERO 2017
          • Beukelman T, Curtis JR, Saag KG.
            Serious Infections in Childhood-Onset Systemic Lupus Erythematosus: Using Administrative Claims Data to Investigate Disease Outcomes.
            Arthritis Care Res (Hoboken). 2017 Feb 19. doi: 10.1002/acr.23221. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28217857
          • Basu B, Roy B, Babu BG.
            Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis.
            Pediatr Nephrol. 2017 Feb 12. doi: 10.1007/s00467-017-3583-x. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28191596
          • Tian SY, Silverman ED, Pullenayegum E, Brown PE, Beyene J, Feldman BM.
            Comparative effectiveness of mycophenolate mofetil for the treatment of childhood-onset proliferative lupus nephritis.
            Arthritis Care Res (Hoboken). 2017 Feb 9. doi: 10.1002/acr.23215. [Epub ahead of print]  https://www.ncbi.nlm.nih.gov/pubmed/28182833
          • Sönmez HE, Karhan AN, Batu ED, Bilginer Y, Gümüş E, Demir H, Yüce A, Özen S.
            Gastrointestinal system manifestations in juvenile systemic lupus erythematosus.
            Clin Rheumatol. 2017 Feb 16. doi: 10.1007/s10067-017-3571-3. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28204893
          • Raeeskarami SR, Shahbaznejad L, Assari R, Aghighi Y.
            Pseudotumor Cerebri as the First Manifestation of Juvenile Systemic Lupus Erythematosus.
            Iran J Pediatr. 2016 Jul 12;26(5):e5176. doi: 10.5812/ijp.5176. eCollection 2016.
            https://www.ncbi.nlm.nih.gov/pubmed/28203329
          • Kotait MA, Abd Elnabi HH, Gabr TA.
            Juvenile systemic lupus erythematosus (jSLE): Auditory pathway affection in relation to disease activity.
            Int J Pediatr Otorhinolaryngol. 2017 Feb;93:150-156. doi: 10.1016/j.ijporl.2016.12.007. Epub 2016 Dec 18.
            https://www.ncbi.nlm.nih.gov/pubmed/28109488
          • Harris JG, Maletta KI, Kuhn EM, Olson JC.
            Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients.
            Clin Rheumatol. 2017 Feb;36(2):351-359. doi: 10.1007/s10067-016-3518-0. Epub 2016 Dec 24.
            https://www.ncbi.nlm.nih.gov/pubmed/28013435
          • Fatemi A, Matinfar M, Smiley A.
            Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality.
            Clin Rheumatol. 2017 Feb;36(2):343-350. doi: 10.1007/s10067-016-3509-1. Epub 2016 Dec 23.
            https://www.ncbi.nlm.nih.gov/pubmed/28012055
          • Novak GV, Marques M, Balbi V, Gormezano NW, Kozu K, Sakamoto AP, Pereira RM, Terreri MT, Magalhães CS, Guariento A, Sallum AM, Marini R, Ferriani VP, Barbosa CM, de Castro TC, Ramos VC, Bonfá E, Silva CA.
            Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus.
            Autoimmun Rev. 2017 Feb;16(2):132-135. doi: 10.1016/j.autrev.2016.12.004. Epub 2016 Dec 14.
            https://www.ncbi.nlm.nih.gov/pubmed/27988434
ENERO 2017
  • Lim LS, Pullenayegum E, Lim L, Gladman D, Feldman B, Silverman E.
    From Childhood to Adulthood: The Trajectory of Damage in Patients with Childhood-Onset Systemic Lupus Erythematosus.
    Arthritis Care Res (Hoboken). 2017 Jan 24. doi: 10.1002/acr.23199. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28118527
  • Nanthapisal S, Omoyinmi E, Murphy C, Standing A, Eisenhut M, Eleftheriou D, Brogan PA.
    Early-Onset Juvenile SLE Associated With a Novel Mutation in Protein Kinase C δ.
    Pediatrics. 2017 Jan;139(1). pii: e20160781. doi: 10.1542/peds.2016-0781. Epub 2016 Dec 21.
    https://www.ncbi.nlm.nih.gov/pubmed/28003329
  • Fonseca R, Aguiar F, Rodrigues M, Brito I.
    Clinical phenotype and outcome in lupus according to age: a comparison between juvenile and adult onset.
    Reumatol Clin. 2016 Dec 28. pii: S1699-258X(16)30156-5. doi: 10.1016/j.reuma.2016.10.011. [Epub ahead of print] English, Spanish.
    https://www.ncbi.nlm.nih.gov/pubmed/28012055

 

DICIEMBRE 2016
          • AlE'ed A, Vega-Fernandez P, Muscal E, Hinze C, Tucker LB, Appenzeller S, Bader-Meunier B, Roth J, Torrente-Segarra V, Klein-Gitelman MS, Levy DM, Roebuck-Spencer T, Brunner H; CARRA NPSLE Working Group.
            The Challenges of Diagnosing Cognitive Dysfunction with Neuropsychiatric Systemic Lupus Erythematosus in Childhood.
            Arthritis Care Res (Hoboken). 2016 Dec 19.
            https://www.ncbi.nlm.nih.gov/pubmed/27992660
          • Harris JG, Maletta KI, Kuhn EM, Olson JC.
            Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients.
            Clin Rheumatol. 2016 Dec 24.
            https://www.ncbi.nlm.nih.gov/pubmed/28013435
          • Fatemi A, Matinfar M, Smiley A.
            Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality.
            Clin Rheumatol. 2016 Dec 23.
            https://www.ncbi.nlm.nih.gov/pubmed/28012055
          • Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA; UK JSLE Study Group.
            Differences in disease phenotype and severity in SLE across age groups.
            Lupus. 2016 Dec;25(14):1542-1550.
            https://www.ncbi.nlm.nih.gov/pubmed/27147622
          • Sakamoto AP, Silva CA, Ferriani MP, Pereira RM, Bonfá E, Saad-Magalhães C, Okuda E, Appenzeller S, Gomes FH, Cunha AL, Salume MH, Piotto DP, Terreri MT.
            Characterization of chronic arthritis in a multicenter study of 852 childhood-onset systemic lupus erythematosus patients.
            Rheumatol Int. 2016 Dec;36(12):1641-1648.
            https://www.ncbi.nlm.nih.gov/pubmed/27629113
 
NOVIEMBRE 2016
          • van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Balážová P, Bonfa E, Bootsma H, Boumpas D, Bruce I, Cervera R, Clarke A, Coney C, Costedoat-Chalumeau N, Czirják L, Derksen R, Doria A, Dörner T, Fischer-Betz R, Fritsch-Stork R, Gordon C, Graninger W, Györi N, Houssiau F, Isenberg D, Jacobsen S, Jayne D, Kuhn A, Le Guern V, Lerstrøm K, Levy R, Machado-Ribeiro F, Mariette X, Missaykeh J, Morand E, Mosca M, Inanc M, Navarra S, Neumann I, Olesinska M, Petri M, Rahman A, Rekvig OP, Rovensky J, Shoenfeld Y, Smolen J, Tincani A, Urowitz M, van Leeuw B, Vasconcelos C, Voss A, Werth VP, Zakharova H, Zoma A, Schneider M, Ward M.
            A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).
            Ann Rheum Dis. 2016 Nov 24.
            https://www.ncbi.nlm.nih.gov/pubmed/27884822
          • Gomes RC, Silva MF, Kozu K, Bonfá E, Pereira RM, Terreri MT, Magalhães CS, Sacchetti SB, Marini R, Fraga M, Carvalho LM, Barbosa CM, Carneiro-Sampaio M, Silva CA.
            Features of 847 Childhood-Onset Systemic Lupus Erythematosus Patients in Three Age Groups at Diagnosis: A Brazilian Multicenter Study.
            Arthritis Care Res (Hoboken). 2016 Nov;68(11):1736-1741
            https://www.ncbi.nlm.nih.gov/pubmed/27014968
          • Pisetsky DS, Rovin BH, Lipsky PE.
            Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of ANA and anti-DNA.
            Arthritis Rheumatol. 2016 Nov 29
            https://www.ncbi.nlm.nih.gov/pubmed/27899010
          • Massarotti EM, Allore HG, Costenbader K.
            Interferon-Targeted Therapy for SLE: Are the Trials on Target?
            Arthritis Rheumatol. 2016 Nov 11
            https://www.ncbi.nlm.nih.gov/pubmed/27860434
          • Gao R, Yu W, Wen Y, Li H.
            Beta2-glycoprotein-I Expression in Lupus Nephritis Patients with Antiphospholipid-associated Nephropathy.
            J Rheumatol. 2016 Nov;43(11):2026-2032.
            https://www.ncbi.nlm.nih.gov/pubmed/27633824
 
SEPTIEMBRE 2016
          • Smith EM, Jorgensen AL, Midgley A, Oni L, Goilav B, Putterman C, Wahezi D, Rubinstein T, Ekdawy D, Corkhill R, Jones CA, Marks SD, Newland P, Pilkington C, Tullus K, Beresford MW.
            International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
            Pediatr Nephrol. 2016 Sep 3.
            https://www.ncbi.nlm.nih.gov/pubmed/27590021
          • Al-Obaidi M, Saunders D, Brown S, Ramsden L, Martin N, Moraitis E, Pilkington CA, Brogan PA, Eleftheriou D.
            Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus.
            Clin Rheumatol. 2016 Oct;35(10):2449-56.
            https://www.ncbi.nlm.nih.gov/pubmed/27527090
          • Fotis L, Baszis KW, White AJ, French AR.
            Four Cases of Anti-PM/Scl Antibody-positive Juvenile Overlap Syndrome with Features of Myositis and Systemic Sclerosis.
            J Rheumatol. 2016 Sep;43(9):1768-9.
            https://www.ncbi.nlm.nih.gov/pubmed/27587018
 
AGOSTO 2016
          • Sakamoto AP, Silva CA, Ferriani MP, Pereira RM, Bonfá E, Saad-Magalhães C, Okuda E, Appenzeller S, Gomes FH, Cunha AL, Salume MH, Piotto DP, Terreri MT.
            Characterization of chronic arthritis in a multicenter study of 852 childhood-onset systemic lupus erythematosus patients.
            Rheumatol Int. 2016 Sep 14. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/27629113
          • Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczyński P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C; EMBODY Investigator Group.
            Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results from the Phase 3, Randomized, Double-blind, Placebo-controlled Trials, EMBODY™ 1 and EMBODY™ 2.
            Arthritis Rheumatol. 2016 Sep 6. doi: 10.1002/art.39856. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/27598855
          • Iudici M, Fasano S, Gabriele Falcone L, Pantano I, La Montagna G, Migliaresi S, Valentini G.
            Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study.
            Rheumatology (Oxford). 2016 Sep;55(9):1623-30
            http://www.ncbi.nlm.nih.gov/pubmed/27247433
          • Singh JA, Hossain A, Kotb A, Oliveira A, Mudano AS, Grossman J, Winthrop K, Wells GA.
            Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis.
            J Rheumatol. 2016 Sep 1. pii: jrheum.160041. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27585688
          • König N, Fiehn C, Wolf C, Schuster M, Cura Costa E, Tüngler V, Alvarez HA, Chara O, Engel K, Goldbach-Mansky R, Günther C, Lee-Kirsch MA.
            Familial chilblain lupus due to a gain-of-function mutation in STING.
            Ann Rheum Dis. 2016 Aug 26. pii: annrheumdis-2016-209841. doi: 10.1136/annrheumdis-2016-209841. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27566796
 
JULIO 2016
          • Brunner HI, Bennett MR, Abulaban K, Klein-Gitelman MS, O'Neil KM, Tucker L, Ardoin SP, Rouster-Stevens KA, Onel KB, Singer NG, Anne Eberhard B, Jung LK, Imundo L, Wright TB, Witte D, Rovin BH5 Ying J, Devarajan P.
            Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults.
            Arthritis Care Res (Hoboken). 2016 Jul;68(7):1003-11. doi: 10.1002/acr.22762.
            http://www.ncbi.nlm.nih.gov/pubmed/26473509
 
JUNIO 2016
          • Knight AM, Vickery ME, Muscal E, Davis AM, Harris JG, Soybilgic A, Onel KB, Schanberg LE, Rubinstein T, Gottlieb BS, Mandell DS, von Scheven E; CARRA Investigators.
            Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada.
            J Rheumatol. 2016 Jun;43(6):1136-45. doi: 10.3899/jrheum.151228.
          • Cimaz R.
            Paediatric rheumatic disease: Phenotype and prognosis of juvenile systemic lupus erythematosus.
            Nat Rev Rheumatol. 2016 Jul;12(7):382-3. doi: 10.1038/nrrheum.2016.101. Epub 2016 Jun 16.
          • Tunnicliffe DJ, Singh-Grewal D, Chaitow J, Mackie F, Manolios N, Lin MW, O'neill SG, Ralph AF, Craig JC, Tong A.
            Lupus Means Sacrifices: Perspectives of Adolescents and Young Adults With Systemic Lupus Erythematosus.
            Arthritis Care Res (Hoboken). 2016 Jun;68(6):828-37. doi: 10.1002/acr.22749
            http://www.ncbi.nlm.nih.gov/pubmed/26414860
          • Thorbinson C, Oni L, Smith E, Midgley A, Beresford MW.
            Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.
            Paediatr Drugs. 2016 Jun;18(3):181-95. doi: 10.1007/s40272-016-0170-8.
            http://www.ncbi.nlm.nih.gov/pubmed/26971103
 
MAYO 2016
          •  Abujam B, Gupta A, Suri D, Rawat A, Singh S.
            Trends and predictors of mortality in childhood onset lupus in a single North-Indian centre over 23 years: a retrospective study.
            Clin Exp Rheumatol. 2016 Apr 15. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27086699
          • Joo YB, Park SY, Won S, Bae SC.
            Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study.
            J Rheumatol published online before print June 1, 2016. doi: 10.3899/jrheum.151129.
            http://www.jrheum.org/content/early/2016/05/26/jrheum.151129.abstract
          • Knight AM, Vickery ME, Muscal E, Davis AM, Harris JG, Soybilgic A, et al.  
            Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada.
            J Rheumatol June 2016 43(6):1136-1145; published online before print April 1, 2016. doi: 10.3899/jrheum.151228
            http://www.jrheum.org/content/43/6/1136.abstract
          • Pereira KM, Faria AG, Liphaus BL, Jesus AA, Silva CA, Carneiro-Sampaio M, et al.
            Low C4, C4A and C4B gene copy numbers are stronger risk factors for juvenile-onset than for adult-onset systemic lupus erythematosus.Rheumatology (2016) 55 (5):869-873. doi: 10.1093/rheumatology/kev436
            http://rheumatology.oxfordjournals.org/content/55/5/869.abstract
 
ABRIL 2016
          • Banchereau R, Hong S, Cantarel B, Baldwin N, Baisch J, Edens M, Cepika AM, Acs P, Turner J, Anguiano E, Vinod P, Kahn S, Obermoser G, Blankenship D, Wakeland E, Nassi L, Gotte A, Punaro M, Liu YJ, Banchereau J, Rossello-Urgell J, Wright T, Pascual V.
            Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients.
            Cell. 2016 Apr 21;165(3):551-65. doi: 10.1016/j.cell.2016.03.008. Epub 2016 Mar 31.
            http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27040498
          • George A, Wong-Pak A, Peschken CA, Silverman E, Pineau C, Smith CD, Arbillaga H, Zummer M, Bernatsky S, Hudson M, Hitchon C, Fortin PR, Nevskaya T, Pope JE; 1000 Faces of LupusInvestigators.
            The influence of education on disease activity and damage in systemic lupus erythematous: Data from the 1000 Canadian Faces of Lupus
            Arthritis Care Res (Hoboken). 2016 Apr 25. doi: 10.1002/acr.22922. [Epub ahead of print] http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27110869
 
MARZO 2016
          • Gomes RC, Silva MF, Kozu K, Bonfá E, Pereira RM, Terreri MT, Magalhães CS, et al.
            Features of 847 Childhood-Onset Systemic Lupus Erythematousus Patients in Three Age Groups at Diagnosis: A Brazilian Multicenter Study.
            Arthritis Care Res (Hoboken). 2016 Mar 25. doi: 10.1002/acr.22881. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27014968
          • Sousa S, Gonçalves MJ, Inês LS, Eugénio G, Jesus D, Fernandes S, et al.
            Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register.
            Rheumatol Int. 2016 Mar 15. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26979603
          • Lube GE, Ferriani MP, Campos LM, Terreri MT, Bonfá E, Magalhães CS, Aikawa NE, Piotto DP, Peracchi OA, Dos Santos MC, Appenzeller S, Ferriani VP, Pereira RM, Silva CA.
            Evans Syndrome at Childhood-Onset Systemic Lupus Erythematosus Diagnosis: A Large Multicenter Study.
            Pediatr Blood Cancer. 2016 Mar 28. doi: 10.1002/pbc.25976. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27018636
          • Khamashta M, Merrill JT, Werth VP, Furie R, Kalunian K, Illei GG, Drappa J, Wang L, Greth W; CD1067 study investigators.
            Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
            Ann Rheum Dis. 2016 Mar 23. pii: annrheumdis-2015-208562. doi: 10.1136/annrheumdis-2015-208562. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27009916
          • Driest KD, Sturm MS, O'Brien SH, Spencer CH, Stanek JR, Ardoin SP; CARRA Registry Investigators.
            Factors associated with thrombosis in pediatric patients with systemic lupus erythematosus.
            Lupus. 2016 Mar 14. pii: 0961203316638164. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26980741
          • AlKharafi NN, Alsaeid K, AlSumait A, Al-Sabah H, Al-Ajmi H, Rahim JA, Al-Enezi H, Nanda A.
            Cutaneous Lupus Erythematosus in Children: Experience from a Tertiary Care Pediatric Dermatology Clinic.
            Pediatr Dermatol. 2016 Mar;33(2):200-8. doi: 10.1111/pde.12788.
            http://www.ncbi.nlm.nih.gov/pubmed/27001318
          • Lapa AT, Postal M, Sinicato NA, Ferreira WG, Bellini BS, Fernandes PT, Rittner L, Marini R, Cendes F, Appenzeller S.
            Reduction of cerebral and corpus callosum volumes in childhood-onset systemic lupus erythematosus. A volumetric magnetic resonance imaging analysis.
            Arthritis Rheumatol. 2016 Mar 18. doi: 10.1002/art.39680. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26991912
          • Son MB, Sergeyenko Y, Guan H, Costenbader KH.
            Disease activity and transition outcomes in a childhood-onset systemic lupus erythematosus cohort.
            Lupus. 2016 Mar 23. pii: 0961203316640913. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/27013665
          • Cho H, Kim YW, Suh CH, Jung JY, Um YJ, Jung JH, Kim HA.
            Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.
            Lupus. 2016 Mar 15. pii: 0961203316639381. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/26985011
          • Wei LQ, Liang YG, Zhao Y, Liang HT, Qin DC, She MC.
            Efficacy and Safety of Belimumab Plus Standard Therapy in Patients With Systemic Lupus Erythematosus: A Meta-analysis.
            Clin Ther. 2016 Mar 24. pii: S0149-2918(16)30091-1. doi: 10.1016/j.clinthera.2016.02.022. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27021607
          • Danion F, Rosine N, Belkhir R, Gottenberg JE, Hachulla E, Chatelus E, et al for the Club Rhumatismes et Inflammation section of the French Society of Rheumatology.
            Efficacy of abatacept in systemic lupus erythematosus: a retrospective analysis of 11 patients with refractory disease.
            Lupus. 2016 Mar 24. pii: 0961203316640911. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27013663
          • Mok MY, Shoenfeld Y.
            Recent advances and current state of immunotherapy in systemic lupus erythematosus.
            Expert Opin Biol Ther. 2016 Mar 31. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/27032059
          • Ruiz-Larrañaga O, Migliorini P, Uribarri M, Czirják L, Alcaro MC, Del Amo J, Iriondo M, Manzano C, Escorza-Treviño S, Estonba A.
            Genetic association study of systemic lupus erythematosus and disease subphenotypes in European populations.
            Clin Rheumatol. 2016 Mar 28. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27021335
          • María Pego-Reigosa J, Lois-Iglesias A, Rúa-Figueroa Í, Galindo M, Calvo-Alén J, de Uña-Álvarez J, et al.
            Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry.
            Rheumatology (Oxford). 2016 Mar 27. pii: kew049. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27018057
          • Shimizu Y, Yasuda S, Kako Y, Nakagawa S, Kanda M, Hisada R, et al.
            Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE.
            Autoimmun Rev. 2016 Mar 22. pii: S1568-9972(16)30074-X. doi: 10.1016/j.autrev.2016.03.017. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27016478
          • Galindo-Izquierdo M, Rodriguez-Almaraz E, Pego-Reigosa JM, López-Longo FJ, Calvo-Alén J, Olivé A, et al. RELESSER Group, from the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER).
            Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).
            Medicine (Baltimore). 2016 Mar;95(9):e2891. doi: 10.1097/MD.0000000000002891.
            http://www.ncbi.nlm.nih.gov/pubmed/26945378
          • Fors Nieves CE, Izmirly PM.
            Mortality in Systemic Lupus Erythematosus: an Updated Review.
            Curr Rheumatol Rep. 2016 Apr;18(4):21. doi: 10.1007/s11926-016-0571-2.
            http://www.ncbi.nlm.nih.gov/pubmed/26984805
          • Wu H, Zhao M, Tan L, Lu Q.
            The key culprit in the pathogenesis of systemic lupus erythematosus: Aberrant DNA methylation
            Autoimmun Rev. 2016 Mar 10. pii: S1568-9972(16)30050-7. doi: 10.1016/j.autrev.2016.03.002. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26970492     
          • Buers I, Nitschke Y, Rutsch F.
            Novel interferonopathies associated with mutations in RIG-I like receptors.
            Cytokine Growth Factor Rev. 2016 Mar 11. pii: S1359-6101(16)30044-2. doi: 10.1016/j.cytogfr.2016.03.005. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26993858
          • Pinto AJ, Roschel H, Benatti FB, de Sá Pinto AL, Sallum AM, Silva CA, Gualano B.
            Poor agreement of objectively measured and self-reported physical activity in juvenile dermatomyositis and juvenile systemic lupus erythematosus.
            Clin Rheumatol. 2016 Mar 28. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27021334
 
FEBRERO 2016
          • van Weelden M, Queiroz LB, Lourenço DM, Kozu K, Lourenço B, Silva CA.
            Alcohol, smoking and illicit drug use in pediatric systemic lupus erythematosus patients.
            Rev Bras Reumatol. 2016 Feb 5. pii: S0482-5004(16)00007-3. doi: 10.1016/j.rbr.2015.10.003. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26949149
          • Carbajal-Alonso HL, García-Moreno NP, Rodríguez-Arreola B, Barrera de León JC.
            Depressive disorder in Mexican pediatric patients with systemic lupus erythematosus (SLE)
            Gac Med Mex. 2016 Jan-Feb;152(1):36-42.
            http://www.ncbi.nlm.nih.gov/pubmed/26927642
          • Guidelines for the clinical practice based on the literature and expert opinion.
            Mathian A, Arnaud L, Adoue D, Agard C, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L,Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O,Miyara M, Morell-Dubois S, Ninet J, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Sibilia J, Viallard JF, Viau Brabant A, Hanslik T, Amoura Z; le groupe France lupus érythémateux systémique réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.
            Prevention of infections in adults and adolescents with systemic lupus erythematosus
            Rev Med Interne. 2016 Feb 15. pii: S0248-8663(16)00032-1. doi: 10.1016/j.revmed.2016.01.005. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26899776
          • Lupus. 2016 Feb 4. pii: 0961203316629554. [Epub ahead of print] Subclinical pulmonary abnormalities in childhood-onset systemic lupus erythematosus patients.
            Veiga CS, Coutinho DS, Nakaie CM, Campos LM, Suzuki L, Cunha MT, Leone C, Silva CA, Rodrigues JC.
            http://www.ncbi.nlm.nih.gov/pubmed/26849883
 
ENERO 2016
          • Barsalou J, Bradley TJ, Tyrrell PN, Slorach C, Ng LW, Levy DM, Silverman ED.
            Impact of Disease Duration on Vascular Surrogates of Early Atherosclerosis in Childhood-Onset Systemic Lupus Erythematosus.
            Arthritis Rheumatol. 2016 Jan;68(1):237-46. doi: 10.1002/art.39423.
            http://onlinelibrary.wiley.com/doi/10.1002/art.39423/abstract
          • Lima GL, Paupitz J, Aikawa NE, Takayama L, Bonfa E, Pereira RM.
            Vitamin D Supplementation in Adolescents and Young Adults With Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double-Blind, Placebo-Controlled Trial.
            Arthritis Care Res (Hoboken). 2016 Jan;68(1):91-8. doi: 10.1002/acr.22621.
            http://onlinelibrary.wiley.com/doi/10.1002/acr.22621/abstract
          • Ferreira JC, Marques HH, Ferriani MP, Gormezano NW, Terreri MT, Pereira RM, Magalhães CS, Campos LM, Bugni V, Okuda EM, Marini R, Pileggi GS, Barbosa CM, Bonfá E, Silva CA.
            Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study.
            Lupus. 2016 Jan 27. pii: 0961203315627203. [Epub ahead of print] http://lup.sagepub.com/content/early/2016/01/27/0961203315627203.abstract
 
DICIEMBRE 2015
          • Martínez-Barrio J, Ovalles-Bonilla JG, López-Longo FJ, González CM, Montoro M, Valor L, Martínez LP, Nieto JC, Hinojosa-Dávila MC, Bello N, Monteagudo I, Naredo E, Carreño L.
            Juvenile, adult and late-onset systemic lupus erythematosus: a long term follow-up study from a geographic and ethnically homogeneous population
            Clin Exp Rheumatol. 2015 Nov-Dec;33(6):788-94
            http://www.ncbi.nlm.nih.gov/pubmed/26575830
          • Silva MF, Ferriani MP, Terreri MT, Pereira RM, Magalhães CS, Bonfá E, Campos LM, Okuda EM, Appenzeller S, Ferriani VP, Barbosa CM, Ramos VC, Lotufo S, Silva CA.
            A Multicenter Study of Invasive Fungal Infections in Patients with Childhood-onset Systemic Lupus Erythematosus.
            J Rheumatol. 2015 Dec;42(12):2296-303. doi: 10.3899/jrheum.150142.
            http://www.ncbi.nlm.nih.gov/pubmed/26568586
          • Yang Y, Kumar S, Lim LS, Silverman ED, Levy DM.
            Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus.

            J Rheumatol. 2015 Dec;42(12):2304-9. doi: 10.3899/jrheum.150464.
            http://www.ncbi.nlm.nih.gov/pubmed/26568601
          • Pesickova SS, Rysava R, Lenicek M, Vitek L, Potlukova E, Hruskova Z, Jancova E, Honsova E, Zavada J, Trendelenburg M, Tesar V.
            Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up.

            Arthritis Res Ther. 2015 Dec 24;17(1):371. doi: 10.1186/s13075-015-0879-8.
            http://www.ncbi.nlm.nih.gov/pubmed/26704903
 
NOVIEMBRE 2015
          • Hermine I Brunner, Michael Bennett, Khalid Abulaban, Marisa Klein-Gitelman, Kathleen O'Neil, Lori Tucker, Stacy Ardoin, Kelly Rouster-Stevens, Karen Onel, Nora Singer, B. Anne Eberhard, Larry Jung, Lisa Imundo, Tracey Wright, David Witte, Brad Rovin, Jun Ying and Prasad Devarajan
            Development of a novel renal activity index of lupus nephritis in children & young adults

            Arthritis Care & Research
            DOI: 10.1002/acr.22762
            Abstract 
          • Frances Rees, Michael Doherty, Matthew Grainge, Peter Lanyon, Graham Davenport and Weiya Zhang
            The burden of co-morbidity in Systemic Lupus Erythematosus in the United Kingdom 1999-2012

            Arthritis Care & Research
            DOI: 10.1002/acr.22751
            Abstract
          • David J Tunnicliffe, Davinder Singh-Grewal, Jeffrey Chaitow, Fiona Mackie, Nicholas Manolios, Ming-Wei Lin, Sean G O'Neill, Angelique F Ralph, Jonathan C Craig and Allison Tong
            “Lupus means sacrifices” – the perspectives of adolescents and young adults with systemic lupus erythematosus
            Arthritis Care & Research
            DOI: 10.1002/acr.22749
            Abstract
          • Susanna Felsenstein, Andreas O. Reiff and Anusha Ramanathan
            Transition of Care and Health-Related Outcomes in Pediatric-Onset Systemic Lupus Erythematosus (pages 1521–1528)

            Arthritis Care & Research
            DOI: 10.1002/acr.22611
            Abstract
          • J. Martínez-Barrio, J. Ovalles-Bonilla, F. López-Longo, C. González, M. Montoro, L. Valor, L. Martínez, J. Nieto, M. Hinojosa-Dávila, N. Bello, I. Monteagudo, E. Naredo, L. Carreño
            Juvenile, adult and late-onset systemic lupus erythematosus: a long term follow-up study from a geographic and ethnically homogeneous population.

            Clinical and Experimental Rheumatology
          • Yogita Ghodke-Puranik, Timothy B. Niewold
            Immunogenetics of systemic lupus erythematosus: A comprehensive review
            Journal of Autoimmunity
            Volume 64, November 2015, Pages 125–136
          • J O Sato, J E Corrente, C Saad-Magalhães
            Chronic active disease pattern predicts early damage in juvenile systemic lupus erythematosus

            Lupus. 10.1177/0961203315599449 Lupus
            November 2015 vol. 24 no. 13 1421-1428
          • Andrea Knight, Michelle Vickery, Alexander Fiks, Frances Barg
            Barriers and facilitators for mental healthcare in pediatric lupus and mixed connective tissue disease: a qualitative study of youth and parent perspectives

            Pediatric Rheumatology 2015, 13:52 (24 November 2015)
            Abstract
 
OCTUBRE 2015
          • Tunnicliffe DJ, Singh-Grewal D, Chaitow J, Mackie F, Manolios N, Lin MW, O'Neill SG, Ralph AF, Craig JC, Tong A
            Lupus means sacrifices" - the perspectives of adolescents and young adults with systemic lupus erythematosus
            Arthritis Care Res (Hoboken). 2015 Sep 28. doi: 10.1002/acr.22749. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26414860
          • Hannah J, Casian A, D'Cruz D.
            Tacrolimus use in lupus nephritis: A systematic review and meta-analysis.
            Autoimmun Rev. 2015 Sep 30. pii: S1568-9972(15)00201-3. doi: 10.1016/j.autrev.2015.09.006. [Epub ahead of print] Review.
            http://www.ncbi.nlm.nih.gov/pubmed/26427983
          • Brunner HI, Bennett M, Abulaban K, Klein-Gitelman M, O'Neil K, Tucker L, Ardoin S, Rouster-Stevens K, Onel K, Singer N, Eberhard BA, Jung L, Imundo L, Wright T, Witte D, Rovin B, Ying J, Devarajan P.
            Development of a novel renal activity index of lupus nephritis in children & young adults
            Arthritis Care Res (Hoboken). 2015 Oct 16. doi: 10.1002/acr.22762. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26473509
 
SEPTIEMBRE 2015
          • Fernandes EC, Silva CA, Braga AL, Sallum AM, Campos LM, Farhat SC.
            Exposure to Air Pollutants and Disease Activity in Juvenile-Onset Systemic Lupus Erythematosus Patients.
            Arthritis Care Res (Hoboken). 2015 Nov;67(11):1609-14. doi: 10.1002/acr.22603.
            http://www.ncbi.nlm.nih.gov/pubmed/25892357
 
AGOSTO 2015
          • Sato JO, Corrente JE, Saad-Magalhães C.
            Chronic active disease pattern predicts early damage in juvenile systemic lupus erythematosus.
            Lupus. 2015 Aug 7. pii:0961203315599449. EPUB ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/26253073
          • Alqanatish JT.
            Lingual Infarction in a Child With Systemic Lupus Erythematosus.
            J Clin Rheumatol. 2015 Sep;21(6):319.doi:10.1097/RHU.0000000000000284.
            http://www.ncbi.nlm.nih.gov/pubmed/26308351  
          • Borgia RE, Silverman ED.
            Childhood-onset systemic lupus erythematosus: an update.
            Curr Opin Rheumatol. 2015 Sep;27(5):483-92. doi:10.1097/BOR.0000000000000208.
            http://www.ncbi.nlm.nih.gov/pubmed/26200474
 
JULIO 2015
          • Mina R, Abulaban K, Klein-Gitelman M, Eberhard A, Ardoin S, Singer N, Onel K, Tucker L, O'Neil K, Wright T, Brooks E, Rouster-Stevens K, Jung L, Imundo L, Rovin B, Witte D, Ying J, Brunner HI
            Validation of the lupus nephritis clinical indices in childhood-onset systemic lupus erythematosus.
            Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22651. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26213987
          • Jones JT, Cunningham N, Kashikar-Zuck S, Brunner HI
            Pain, Fatigue and Psychological Impact on Health-related Quality of Life in Childhood-onset Lupus.
            Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22650. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26195020
          • Sule SD, Moodalbail DG, Burnham J, Fivush B, Furth SL
            Predictors of arthritis in pediatric patients with lupus.
            Pediatr Rheumatol Online J. 2015 Jul 14;13(1):30. doi: 10.1186/s12969-015-0027-7.
            http://www.ncbi.nlm.nih.gov/pubmed/26170222
 
JUNIO 2015
          • Kalunian KC, Merrill JT, Maciuca R, McBride JM, Townsend MJ, Wei X, Davis JC Jr, Kennedy WP.
            A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).
            Ann Rheum Dis. 2015 Jun 2. pii: annrheumdis-2014-206090. doi: 10.1136/annrheumdis-2014-206090. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26038091
          •  Alexander T, Sarfert R, Klotsche J, Kühl AA, Rubbert-Roth A, Lorenz HM, Rech J, Hoyer BF, Cheng Q, Waka A, Taddeo A, Wiesener M, Schett G, Burmester GR, Radbruch A, Hiepe F, Voll RE.
            The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.
            Ann Rheum Dis. 2015 Jul;74(7):1474-8. doi: 10.1136/annrheumdis-2014-206016. Epub
            http://www.ncbi.nlm.nih.gov/pubmed/25710470
          •  Haddon DJ, Diep VK, Price JV, Limb C, Utz PJ and Balboni I
            Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus
            Arthritis Research & Therapy 2015, 17:162
            http://www.ncbi.nlm.nih.gov/pubmed/26081107
          •  Soybilgic A.
            Neuropsychiatric Systemic Lupus Erythematosus in Children.
            Pediatr Ann. 2015 Jun 1;44(6):e153-e158. doi: 10.3928/00904481-20150611-11.
            http://www.ncbi.nlm.nih.gov/pubmed/26114371
          • Mirabelli G, Cannarile F, Bruni C, Vagelli R, De Luca R, Carli L.
            One year in review 2015: systemic lupus erythematosus.
            Clin Exp Rheumatol. 2015 May-Jun;33(3):414-25.
            http://www.ncbi.nlm.nih.gov/pubmed/26106941
 
MAYO 2015
          • Lien Van Eyck, Lien De Somer, Diana Pombal, Simon Bornschein, Glynis Frans, Stéphanie Humblet-Baron, et al
            Brief Report: IFIH1 Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency (pages 1592–1597)
            Arthritis and Rheumatism.
            Article first published online: 25 MAY 2015 | DOI: 10.1002/art.39110
            http://onlinelibrary.wiley.com/doi/10.1002/art.39110/abstract
          • Hermine I. Brunner, Clovis A. Silva, Andreas Reiff, Gloria C. Higgins, Lisa Imundo, Calvin B. Williams, et al.
            Randomized, Double-Blind, Dose-Escalation Trial of Triptorelin for Ovary Protection in Childhood-Onset Systemic Lupus Erythematosus (pages 1377–1385)
            Arthritis and Rheumatism. Article first published online: 27 APR 2015 | DOI: 10.1002/art.39024
            http://onlinelibrary.wiley.com/doi/10.1002/art.39024/abstract
          • Amanda J. Steiman, Murray B. Urowitz, Dominique Ibañez, Timothy T. Li, Dafna D. Gladman, and Joan Wither
            Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus
            J Rheumatol May 2015 42(5):810-816; doi:10.3899/jrheum.140796
            http://jrheum.org/content/42/5/810.abstract
          • Leal GN, Silva KF, França CMP, Lianza AC, Andrade JL, Campos LMA et al.
            Subclinical right ventricle systolic dysfunction in childhood-onset systemic lupus erythematosus: insights from two-dimensional speckle-tracking echocardiography.
            Lupus May 2015 vol. 24 no. 6 613-620 doi: 10.1177/0961203314563135
            http://m.lup.sagepub.com/content/24/6/613
          • Helena Enocsson, Christopher Sjöwall, Lina Wirestam, Charlotte Dahle, Alf Kastbom, Johan Rönnelid, Jonas Wetterö, and Thomas Skogh
            Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity
            J Rheumatol May 2015 42(5):817-825; published online before print February 15, 2015, doi:10.3899/jrheum.140677
            http://jrheum.org/content/42/5/817.abstract
          • Pilar Brito-Zerón, Peter M. Izmirly, Manuel Ramos-Casals, Jill P. Buyon & Munther A. Khamashta
            The clinical spectrum of autoimmune congenital heart block.
            Nature Reviews Rheumatology 11, 301–312 (2015) doi:10.1038/nrrheum.2015.29
            http://www.nature.com/nrrheum/journal/v11/n5/abs/nrrheum.2015.29.html
          • John G. Hanly
            Attribution in the assessment of nervous system disease in SLE
            Rheumatology (2015) 54 (5): 755-756 doi:10.1093/rheumatology/keu458
            http://rheumatology.oxfordjournals.org/content/54/5/755.full
 
ABRIL 2015
          • Wilhelmus S, Bajema IM, Bertsias GK, Boumpas DT, Gordon C, Lightstone L, Tesar V, Jayne DR.
            Lupus nephritis management guidelines compared
            Nephrol Dial Transplant. 2015 Apr 28. pii: gfv102. [Epub ahead of print] Review
            http://www.ncbi.nlm.nih.gov/pubmed/25920920
          •  Silpa-Archa S, Lee JJ, Foster CS.
            Ocular manifestations in systemic lupus erythematosus.
            Br J Ophthalmol. 2015 Apr 22. pii: bjophthalmol-2015-306629. doi: 10.1136/bjophthalmol-2015-306629. [Epub ahead of print] Review.
            http://www.ncbi.nlm.nih.gov/pubmed/25904124
            Gurion R, Tangpricha V, Yow E, Schanberg LE, McComsey GA, Robinson AB;
          • Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators.
            Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature.
            Pediatr Rheumatol Online J. 2015 Apr 23;13(1):13. doi: 10.1186/s12969-015-0008-x.
            http://www.ncbi.nlm.nih.gov/pubmed/25902709
            Acceso directo: http://www.ped-rheum.com/content/pdf/s12969-015-0008-x.pdf
          • Mohan S, Barsalou J, Bradley TJ, Slorach C, Reynolds JA, Hasni S, Thompson B, Ng L, Levy D, Silverman E, Kaplan MJ.
            Endothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus
            Arthritis Rheumatol. 2015 Apr 17. doi: 10.1002/art.39149. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25891295
          • Fassbinder T, Saunders U, Mickholz E, Jung E, Becker H, Schlüter B, Jacobi AM.
            Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
            Arthritis Res Ther. 2015 Apr 3;17(1):92. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25890338
          • Bonanni A, Vaglio A, Bruschi M, Sinico RA, Cavagna L, Moroni G, Franceschini F, Allegri L, Pratesi F, Migliorini P, Candiano G, Pesce G, Ravelli A, Puppo F, Martini A, Tincani A, Ghiggeri GM.
            Multi-antibody composition in lupus nephritis: Isotype and antigen specificity make the difference
            Autoimmun Rev. 2015 Apr 14. pii: S1568-9972(15)00086-5. doi:
            0.1016/j.autrev.2015.04.004. [Epub ahead of print] 
            http://www.ncbi.nlm.nih.gov/pubmed/25888464 
          • Dall'Era M, Cisternas MG, Smilek DE, Straub L, Houssiau FA, Cervera R, Rovin BH, Mackay M.
            Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the euro-lupus nephritis cohort
            Arthritis Rheumatol. 2015 May;67(5):1305-13. doi: 10.1002/art.39026.
            http://www.ncbi.nlm.nih.gov/pubmed/25605554
          • Brunner HI1, Silva CA, Reiff A, Higgins GC, Imundo L, Williams CB, Wallace CA, Aikawa NE, Nelson S, Klein-Gitelman MS, Rose SR.
            Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus
            Arthritis Rheumatol. 2015 May;67(5):1377-85. doi: 10.1002/art.39024.
            http://www.ncbi.nlm.nih.gov/pubmed/25676588
 
MARZO 2015
          • Steiman AJ, UrowitzMB, Ibañez D, Li TT, Gladman DD, Wither J.
            Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
            J Rheumatol. 2015 Mar 1. pii: jrheum.140796. [Epub ahead of print].
            http://www.ncbi.nlm.nih.gov/pubmed/25729033
          • Ding JY, Ibañez D, Gladman DD, Urowitz MB.
            Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activity.
            J Rheumatol. 2015 Mar;42(3):437-40. doi: 10.3899/jrheum.140415.
            http://www.ncbi.nlm.nih.gov/pubmed/25593226
          • Olfat M, Silverman ED, Levy DM.
            Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
            Lupus. 2015 Mar 24. pii: 0961203315578764. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25804672
          • Doria A, Gatto M, Iaccarino L, Punzi L
            Value and goals of treat-to-target in systemic lupus erythematosus: knowledge and foresight.
            Lupus. 2015 Apr;24(4-5):507-15. doi: 10.1177/0961203314559087
            http://www.ncbi.nlm.nih.gov/pubmed/25801894
          • Watson P, Brennan A, Birch H, Fang H, Petri M.
            An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins Lupus Cohort
            Rheumatology (2015) 54 (4): 623-632. doi:10.1093/rheumatology/keu375
            http://rheumatology.oxfordjournals.org/content/54/4/623.abstract
          • Castrejon I, Carmona L, Agrinier N, Andres M, Briot K, Caron M, Christensen R, Consolaro A, Curbelo R, Ferrer M, Foltz V, Gonzalez C, Guillemin F, Machado PM, Prodinger B, Ravelli A, Scholte-Voshaar M, Uhlig T, van Tuyl LH, Zink A, Gossec L.
            The EULAR Outcome Measures Library: development and an example from a systematic review for systemic lupus erythematous instruments
            Clin Exp Rheumatol. 2015 Mar 23. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25797345
          • Roldan CA, Tolstrup K, Macias L, Qualls CR, Maynard D, Charlton G, Sibbitt WL Jr.
            Libman-Sacks Endocarditis: Detection, Characterization, and Clinical Correlates by Three-Dimensional Transesophageal Echocardiography
            J Am Soc Echocardiogr. 2015 Mar 22. pii: S0894-7317(15)00130-3
            http://www.ncbi.nlm.nih.gov/pubmed/25807885
          • Merayo-Chalico J, Apodaca E, Barrera-Vargas A, Alcocer-Varela J, Colunga-Pedraza I, González-Patiño A, Arauz A, Abud-Mendoza C, Martínez-Martínez M, Gómez-Martín D.
            Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study.
            J Neurol Neurosurg Psychiatry. 2015 Mar 24. pii: jnnp-2014-310145. doi: 10.1136/jnnp-2014-310145. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/25804426
          • Bassi N, Del Prete D, Ghirardello A, Gatto M, Ceol M, Zen M, Bettio S, Mantovani A, Iaccarino L, Punzi L, Doria A.
            PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis
            Clin Rev Allergy Immunol. 2015 Mar 25. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/25805362
          • Kikuchi-Taura A, Yura A, Tsuji S, Ohshima S, Kitatoube A, Shimizu T, Nii T, Katayama M, Teshigawara S, Yoshimura M, Kudo-Tanaka E, Harada Y, Matsushita M, Hashimoto J, Saeki Y.
            Monocyte CD64 expression as a novel biomarker for the disease activity ofsystemic lupus erythematosus
            Lupus. 2015 Mar 24. pii: 0961203315579093. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/25804673
 
FEBRERO 2015
          • Mrabet S, Benrhouma H, Kraoua I, Naas A, Achour NB, Klaa H, Turki I.
            Mixed movements disorders as an initial feature of pediatric lupus.
            Brain Dev. 2015 Feb 28.
            http://www.ncbi.nlm.nih.gov/pubmed/25736974
          • Singh S, Abujam B, Gupta A, Suri D, Rawat A, Saikia B, Walker Minz R, Joshi K, Nada R.
            Childhood lupus nephritis in a developing country-24 years' single-center experience from North India.
            Lupus. 2015 Feb 22.
            http://www.ncbi.nlm.nih.gov/pubmed/25712249
          • Vega-Fernandez P, Vanderburgh White S, Zelko F, Ruth NM, Levy DM, Muscal E, Klein-Gitelman MS, Huber AM, Tucker LB, Roebuck-Spencer T, Ying J, Brunner HI.
            Cognitive performance scores for the pediatric automated neuropsychological assessment metrics in childhood-onset systemic lupus erythematosus.
            Arthritis Care Res (Hoboken). 2015 Feb 23.
            http://www.ncbi.nlm.nih.gov/pubmed/25708844
          • Fotis L, Baszis KW, French AR, Cooper MA, White AJ.
            Mesenteric vasculitis in children with systemic lupus erythematosus.
            Clin Rheumatol. 2015 Feb 17.
            http://www.ncbi.nlm.nih.gov/pubmed/25687984
          • Sule SD, Moodalbail DG, Burnham J, Fivush B, Furth SL.
            Predictors of kidney disease in a cohort of pediatric patients with lupus.
            Lupus. 2015 Feb 12.
            http://www.ncbi.nlm.nih.gov/pubmed/25680740
          • Tambralli A, Beukelman T, Cron RQ, Stoll ML.
            Safety and Efficacy of Rituximab in Childhood-onset Systemic Lupus Erythematosus and Other Rheumatic Diseases.
            J Rheumatol. 2015 Mar;42(3):541-6.
            http://www.ncbi.nlm.nih.gov/pubmed/25593242
 
ENERO 2015
          • Fonseca AR, Gaspar-Elsas MI, Land MG, de Oliveira SK.
            Comparison between three systems of classification criteria in juvenile systemic lupus erythematous.
            Rheumatology (Oxford). 2015 Feb;54(2):241-7. doi: 10.1093/rheumatology/keu278. Epub 2014 Aug 14.
            http://www.ncbi.nlm.nih.gov/pubmed/25125590 
          • Tambralli A, Beukelman T, Cron RQ, Stoll ML.
            Safety and Efficacy of Rituximab in Childhood-onset Systemic Lupus Erythematosus and Other Rheumatic Diseases.
            J Rheumatol. 2015 Jan 15. pii: jrheum.140863. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25593242 
          • Watson L, Beresford MW, Maynes C, Pilkington C, Marks SD, Glackin Y, Tullus K.
            The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE.
            Lupus. 2015 Jan;24(1):10-7. doi: 10.1177/0961203314547793. Epub 2014 Aug 12.
            http://www.ncbi.nlm.nih.gov/pubmed/25117653 
          • Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel K, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K, Ying J, Brunner HI.
            Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus.
            Lupus. 2015 Feb;24(2):191-7. doi: 10.1177/0961203314555537. Epub 2014 Oct 21.
            http://www.ncbi.nlm.nih.gov/pubmed/25335488 
          • Rozenblyum EV, Levy DM, Allen U, Harvey E, Hebert D, Silverman ED.
            Cytomegalovirus in pediatric systemic lupus erythematosus: prevalence and clinical manifestations.
            Lupus. 2015 Jan 6. pii: 0961203314565443. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25568145
 
DICIEMBRE 2014
 
          • Tarr T, Dérfalvi B, Győri N, Szántó A, Siminszky Z, Malik A, Szabó AJ, Szegedi G, Zeher M.
            Similarities and differences between pediatric and adult patients with systemic lupus erythematosus.
            Lupus. 2014 Dec 15. pii: 0961203314563817.
            http://www.ncbi.nlm.nih.gov/pubmed/25516474
          • Mahmoudi M1, Tahghighi F, Ziaee V, Harsini S, Rezaei A, Soltani S, Sadr M, Moradinejad MH, Aghighi Y, Rezaei N.
            Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus.
            Int J Immunogenet. 2014 Dec;41(6):512-7.
            http://www.ncbi.nlm.nih.gov/pubmed/25320043
          • Wei CC, Lin CL, Tsai JD, Shen TC, Sung FC.
            Increased Incidence of juvenile onset systemic lupus erythematosus in children with atopic dermatitis.
            Lupus. 2014 Dec;23(14):1494-9.
            http://www.ncbi.nlm.nih.gov/pubmed/25057040
          • Levy DM, Peschken CA, Tucker LB, Chédeville G, Huber AM, Pope JE; Canadian Network for Improved Outcomes in SLE (CaNIOS) 1000 Faces Investigators, Silverman ED.
            Association of health-related quality of life in childhood-onset systemic lupus erythematosus with ethnicity: results from a multiethnic multicenter canadian cohort.
            Arthritis Care Res (Hoboken). 2014 Dec;66(12):1767-74.
            http://www.ncbi.nlm.nih.gov/pubmed/24821613
          • Leal GN, Silva KF, França CM, Lianza AC, Andrade JL, Campos LM, Bonfá E, Silva CA.
            Subclinical right ventricle systolic dysfunction in childhood-onset systemic lupus erythematosus: insights from two-dimensional speckle-tracking echocardiography.
            Lupus. 2014 Dec 8. pii: 0961203314563135. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25492941
 
NOVIEMBRE 2014
 
Lups Eritematoso Juvenil
            • Stagi S, Cavalli L, Bertini F, Signorini C, Matucci Cerinic M, de Martino M, Brandi ML, Falcini F. Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA).
              Lupus. 2014 Nov;23(13):1392-406.
              http://www.ncbi.nlm.nih.gov/pubmed/?term=25074873
            • Wei CC, Lin CL, Tsai JD, Shen TC, Sung FC.
              Increased Incidence of juvenile onset systemic lupus erythematosus in children with atopic dermatitis.
              Lupus. 2014 Dec;23(14):1494-9.
              http://www.ncbi.nlm.nih.gov/pubmed/?term=25057040 
            • Levy DM, Peschken CA, Tucker LB, Chédeville G, Huber AM, Pope JE; Canadian Network for Improved Outcomes in SLE (CaNIOS) 1000 Faces Investigators, Silverman ED.
              Association of health-related quality of life in childhood-onset systemic lupus erythematosus with ethnicity: results from a multiethnic multicenter canadian cohort.
              Arthritis Care Res (Hoboken). 2014 Dec;66(12):1767-74.
              http://www.ncbi.nlm.nih.gov/pubmed/?term=24821613
            • Mahmoudi M, Tahghighi F, Ziaee V, Harsini S, Rezaei A, Soltani S, Sadr M, Moradinejad MH, Aghighi Y, Rezaei N.
              Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus.
              Int J Immunogenet. 2014 Dec;41(6):512-7.
              http://www.ncbi.nlm.nih.gov/pubmed/?term=25320043
 
Neonatal Lupus
 
OCTUBRE 2014
          • Chiewchengchol D, Midgley A, Sodsai P, Deekajorndech T, Hirankarn N, Beresford MW, Edwards SW.
            The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients.
            Clin Rheumatol. 2014 Oct 26. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25344776 
          • Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel K, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K, Ying J, Brunner HI.
            Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus.
            Lupus. 2014 Oct 21. pii: 0961203314555537. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/25335488 
          • Al Hamzi H1, Alhaymouni B, Al Shaikh A,Al-Mayouf SM.
            Outcome of adult Saudi patients with childhood-onset systemic lupus erythematosus.
            Clin Exp Rheumatol. 2014 Aug 15. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25152255 
          • Alhanouf AlSaleem, Ashwaq AlE’ed, Afaf AlSaghier, Sulaiman M. Al-Mayouf
            Vitamin D status in children with systemic lupus erythematosus and its association with clinical and laboratory parameters
            Clinical Rheumatology  Nov 2014. DOI 10.1007/s10067-014-2811-z                   
            http://link.springer.com/article/10.1007/s10067-014-2811-z
          • F E Mackie,G Kainer, N Adib, C Boros, E J Elliott, R Fahy, et al.
            The national incidence and clinical picture of SLE in children in Australia – a report from the Australian Paediatric Surveillance Unit.
            Lupus. Published online before print October 6, 2014, doi: 10.1177/0961203314552118
            http://m.lup.sagepub.com/content/early/2014/10/06/0961203314552118
          • H-T Chung, Y-L Huang, K-W Yeh, J-L Huang
            Subclinical deterioration of left ventricular function in patients with juvenile-onset systemic lupus erythematosusLupus. Published online before print October 9, 2014, doi: 10.1177/0961203314554249
            http://m.lup.sagepub.com/content/early/2014/10/09/0961203314554249
 
SEPTIEMBRE 2014
          • Knight A, Weiss P, Morales K, Gerdes M, Gutstein A, Vickery M, Keren R.
            Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study.
            Pediatr Rheumatol Online J. 2014 Sep 10;12:42. doi: 10.1186/1546-0096-12-42. eCollection 2014.
            http://www.ncbi.nlm.nih.gov/pubmed/25242900
          • Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del Papa N, Meroni P, Messa P, Sinico AR.
            Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
            Rheumatology 2014 Sep;53 (9):1570-1577.
            http://rheumatology.oxfordjournals.org/content/53/9/1570.abstract
          • Zuniga Zambrano YC, Guevara Ramos JD, Penagos Vargas NE, Benitez Ramirez DC, Ramirez Rodriguez SM, Vargas Niño AC, Izquierdo Bello AH.
            Risk factors for neuropsychiatric manifestations in children with systemic lupus erythematosus: case-control study.
            Pediatr Neurol. 2014 Sep;51(3):403-9.
            http://www.ncbi.nlm.nih.gov/pubmed/25159157
          • Leffler J, Bengtsson AA, Blom AM.
            The complement system in systemic lupus erythematosus: an update.
            Ann Rheum Dis. 2014 Sep;73(9):1601-1606.
            http://www.ncbi.nlm.nih.gov/pubmed/24845390
 
 AGOSTO 2014
          • Kizawa T, Nozawa T, Kikuchi M, Nagahama K, Okudela K, Miyamae T, Imagawa T, Nakamura T, Mori M, Yokota S, Tsutsumi H.
            Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
            Mod Rheumatol. 2014 Aug 27:1-5. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25159157
          • Fonseca AR, Gaspar-Elsas MI, Land MG, de Oliveira SK.
            Comparison between three systems of classification criteria in juvenile systemic lupus erythematous.
            Rheumatology (Oxford). 2014 Aug 14. pii: keu278. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25125590
          • Eltayeb AA1, Sayed DM, Afifi NA, Ibrahim MA, Sheref TM.
            Regulatory T cell subsets in children with systemic lupus erythematosus.
            Clin Rheumatol. 2014 Aug;33(8):1085-91.
            http://www.ncbi.nlm.nih.gov/pubmed/24863846
 
JULIO 2014
          • Peracchi OA1, Terreri MT2, Munekata RV1, Len CA2, Sarni RO1, Lazaretti-Castro M3, Hilário MO1.
            Low serum concentrations of 25-hydroxyvitamin D in children and adolescents with systemic lupus erythematosus.
            Braz J Med Biol Res. 2014 Jul 18;0:0. 
            http://www.ncbi.nlm.nih.gov/pubmed/25055165
          • Wei CC1, Lin CL2, Tsai JD3, Shen TC4, Sung FC5.
            Increased Incidence of juvenile onset systemic lupus erythematosus in children with atopic dermatitis.
            Lupus. 2014 Jul 23. 
            http://www.ncbi.nlm.nih.gov/pubmed/25057040
          • Chan PC1, Yu CH2, Yeh KW1, Horng JT3, Huang JL4.
            Comorbidities of pediatric systemic lupus erythematosus: A 6-year nationwide population-based study.
            J Microbiol Immunol Infect. 2014 Jul 24. 
            http://www.ncbi.nlm.nih.gov/pubmed/25066707
          • Lourenço D1, Cunha Gomes R1, Aikawa N2, Campos L1, Romiti R3, Silva C4.
            Childhood-onset bullous systemic lupus erythematosus.
            Lupus. 2014 Jul 29. 
            http://www.ncbi.nlm.nih.gov/pubmed/25074872
          • Gad GI1, Abdelateef H.
            Function of the audiovestibular system in children with systemic lupus erythematosus.
            Curr Allergy Asthma Rep. 2014 Jul;14(7):446. doi: 10.1007/s11882-014-0446-4.
 
JUNIO 2014
 
MAYO 2014
          • Levy DM1, Peschken CA, Tucker LB, Chédeville G, Huber AM, Pope JE; Canadian Network for Improved Outcomes in SLE (CaNIOS) 1000 Faces Investigators,Silverman ED.
            Health related quality of life in childhood-onset systemic lupus erythematosus is associated with ethnicity: Results from a multiethnic multicenter canadian cohort.
            Arthritis Care Res (Hoboken). 2014 May 12. doi: 10.1002/acr.22363. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24821613
          • Pisoni CN1, Muñoz SA2, Carrizo C3, Cosatti M3, Alvarez A4, Dubinsky D5, Bresan E5, Russo R6, Borgia E6, García M7, Sansinanea P7, Basta MC2, D́amico MA8,Barreira JC8, Lancioni E9, Soriano E9, Cunto CD9, Beron A5, Eimon A3.
            Multicentric prevalence study of anti P ribosomal autoantibodies in juvenile onset systemic lupus erythematosuscompared with adult onset systemic lupus erythematosus.
            Reumatol Clin. 2014 May 7. pii: S1699-258X(14)00083-7. doi: 10.1016/j.reuma.2014.03.007. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24816340
 
ABRIL 2014
          • Boneparth A, Ilowite N; for the CARRA Registry Investigators.
            Comparison of renal response parameters for juvenile membranous plus proliferative lupus nephritis versus isolated proliferative lupus nephritis: a cross-sectional analysis of the CARRA Registry.
            Lupus. 2014 Apr 11. [Epub ahead of print]
          • Ale'ed A, Alsonbul A, Al-Mayouf SM
            Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.
            Rheumatol Int. 2014 Apr;34(4):529-33. doi: 10.1007/s00296-013-2896-8.
            http://www.ncbi.nlm.nih.gov/pubmed/24218286
 
MARZO 2014
          • Chiewchengchol D1, Murphy R, Morgan T, Edwards SW, Leone V, Friswell M, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Mann R, Bailey K, Davidson J, Baildam EM, Pain CE, Cleary G, McCann LJ, Beresford MW; on behalf of the UK JSLE Study Group.
            Mucocutaneousmanifestations in a UKnationalcohort of juvenile onsetsystemiclupuserythematosuspatients.
            Rheumatology (Oxford). 2014 Mar 31. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24692572
          • Smith EM, Foster HE, Gray WK, Taylor-Robinson D, Beresford MW; UK JSLE Study Group.
            Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study.
            Rheumatology (Oxford). 2014 Mar;53(3):557-61. doi: 10.1093/rheumatology/ket402. Epub 2013 Dec 5.
            http://www.ncbi.nlm.nih.gov/pubmed/24310297
          • Watson L, Tullus K, Pilkington C, Chesters C, Marks SD, Newland P, Jones CA, Beresford MW.
            Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study.
            Pediatr Nephrol. 2014 Mar;29(3):397-405. doi: 10.1007/s00467-013-2668-4. Epub 2013 Nov 16.
            http://www.ncbi.nlm.nih.gov/pubmed/24241909
          • Knight AM, Weiss PF, Morales KH, Keren R.
            National trends in pediatric systemic lupus erythematosus hospitalization in the United States: 2000-2009.
            J Rheumatol. 2014 Mar;41(3):539-46. doi: 10.3899/jrheum.130592. Epub 2014 Feb 1.
            http://www.ncbi.nlm.nih.gov/pubmed/24488419
 
FEBERERO 2014
          • Midgley A, Watson L, Beresford MW.
            New insights into the pathogenesis and management of lupus in children.
            Arch Dis Child. 2014 Feb 28. doi: 10.1136/archdischild-2013-304397. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24585754
          • Rozenblyum EV, Allen UD, Silverman ED, Levy DM.
            Cytomegalovirus infection in childhood-onset systemic lupus erythematosus.
            Int J Clin Rheumtol. 2013 Feb;8(1):137-146.
            http://www.ncbi.nlm.nih.gov/pubmed/24527062
          • Toulany A, Katzman DK, Kaufman M, Hiraki LT, Silverman ED.
            Chicken or the egg: anorexia nervosa and systemic lupus erythematosus in children and adolescents.
            Pediatrics. 2014 Feb;133(2):e447-50. doi: 10.1542/peds.2012-3048. Epub 2014 Jan 6.
            http://www.ncbi.nlm.nih.gov/pubmed/24394681
          • Yavuz S, Ece A.
            Mean platelet volume as an indicator of disease activity in juvenile SLE.
            Clin Rheumatol. 2014 Feb 25. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24567240
          • Somers EC, Marder W, Cagnoli P, Lewis EE, Deguire P, Gordon C, Helmick CG, Wang L, Wing JJ, Dhar JP, Leisen J, Shaltis D, McCune WJ.
            Population-based incidence and prevalence of systemic lupus erythematosus: the michigan lupus epidemiology and surveillance program.
            Arthritis Rheumatol. 2014 Feb;66(2):369-78. doi: 10.1002/art.38238.
            http://www.ncbi.nlm.nih.gov/pubmed/24504809
            http://onlinelibrary.wiley.com/doi/10.1002/art.38238/pdf
          • Knight AM, Weiss PF, Morales KH, Keren R.
            National Trends in Pediatric Systemic Lupus Erythematosus Hospitalization in the United States: 2000-2009.
            J Rheumatol. 2014 Feb 1. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24488419
          • Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C.
            The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the georgia lupus registry.
            Arthritis Rheumatol. 2014 Feb;66(2):357-68. doi: 10.1002/art.38239.
            http://www.ncbi.nlm.nih.gov/pubmed/24504808
            http://onlinelibrary.wiley.com/doi/10.1002/art.38239/pdf
          • Amaral B, Murphy G, Ioannou Y, Isenberg DA.
            A comparison of the outcome of adolescent and adult-onset systemic lupus erythematosus.
            Rheumatology (Oxford). 2014 Feb 6. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24505121
          • Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del Papa N, Meroni P, Messa P, Sinico AR.
            Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study
            Rheumatology (Oxford). 2014 Feb 6. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24505125
          • Furie R, Nicholls K, Cheng TT, Houssiau F, Burgos-Vargas R, Chen SL, Hillson JL, Meadows-Shropshire S, Kinaszczuk M, Merrill JT.
            Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study.
            Arthritis Rheumatol. 2014 Feb;66(2):379-89. doi: 10.1002/art.38260.
            http://www.ncbi.nlm.nih.gov/pubmed/24504810
            http://onlinelibrary.wiley.com/doi/10.1002/art.38260/pdf
          • Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel K, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K, Martini A, Ruperto N, Lovell DJ, Brunner HI.
            Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus
            Ann Rheum Dis 2014;73:401-406 doi:10.1136/annrheumdis-2012-202376
            http://ard.bmj.com/content/73/2/401.abstract
          • Ginzler EM, Wallace DJ, Merrill JT, Furie RA, Stohl W, Chatham WW, Weinstein A, McKay JD, McCune WJ, Zhong ZJ, Freimuth WW, Petri MA; LBSL02/99 Study Group.
            Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.
            J Rheumatol. 2014 Feb;41(2):300-9. doi: 10.3899/jrheum.121368. Epub 2013 Nov 1.
            http://www.ncbi.nlm.nih.gov/pubmed/24187095
 
ENERO 2014
          • Lehman TJ, Singh C, Ramanathan A, Alperin R, Adams A, Barinstein L, Moorthy N
            Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide
            Pediatr Rheumatol Online J. 2014 Jan 14;12(1):3. doi: 10.1186/1546-0096-12-3.
          • Son MB, Johnson VM, Hersh AO, Lo MS, Costenbader KH.
            Outcomes in hospitalized pediatric patients with systemic lupus erythematosus.
            Pediatrics. 2014 Jan;133(1):e106-13. doi: 10.1542/peds.2013-1640. Epub 2013 Dec 30.
            http://www.ncbi.nlm.nih.gov/pubmed/24379234
 
DICIEMBRE 2013
          • Stagi S, Cavalli L, Bertini F, Cerinic MM, Brandi ML, Falcini F.
            Cross-sectional and longitudinal evaluation of bone mass and quality in children and young adults with juvenile onset systemic lupus erythematosus (JSLE): role of bone mass determinants analyzed by DXA, PQCT and QUS.
            Lupus. 2014;23(1):57-68. doi: 10.1177/0961203313511679. Epub 2013 Nov 11.
            http://www.ncbi.nlm.nih.gov/pubmed/24218395
 
OCTUBRE 2013
 
SEPTIEMBRE 2013
 
JULIO 2013
          • Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E.
            High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
            Arthritis Care Res (Hoboken). 2013 Jul;65(7):1121-7. doi: 10.1002/acr.21948.
            http://www.ncbi.nlm.nih.gov/pubmed/23818263
 
MAYO 2013
          • Gladman DD, Ibañez D, Ruiz I, Urowitz MB
            Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort study.
            J Rheumatol 2013 May;40(5):630-3. doi: 10.3899/jrheum.121094.
            http://www.ncbi.nlm.nih.gov/pubmed/23457385
          • Rianthavorn P, Chokedeemeeboon C, Deekajorndech T, Suphapeetiporn K.
            Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus.
            Lupus 2013 May 2. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23640982
          • Kohut SA, Williams T, Jayanthikumar J, Landolt-Marticorena C, Lefebvre A, Silverman E, Levy D.
            Depressive symptoms are prevalent in childhood-onset systemic lupus erythematosus (cSLE).
            Lupus. 2013 May 23. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23704369
          • Kohut SA, Williams T, Jayanthikumar J, Landolt-Marticorena C, Lefebvre A, Silverman E, Levy D. Gitelman DR, Klein-Gitelman MS, Ying J, Sagcal-Gironella AC, Zelko F, Beebe DW, Difrancesco M, Parrish T, Hummel J, Beckwith T, Brunner HI.
            Brain morphometric changes associated with childhood-onset systemic lupus erythematosus and neurocognitive deficit.
            Arthritis Rheum 2013 May 10. doi: 10.1002/art.38009. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23666759
          • Ingegnoli F.
            Capillaroscopy abnormalities in relation to disease activity in juvenile systemic lupus erythematosus.
            Microvasc Res 2013 May;87:92-4. doi: 10.1016/j.mvr.2013.02.004. Epub 2013 Feb 26.
            http://www.ncbi.nlm.nih.gov/pubmed/23485586
          • Mok CC, Ho LY, Fong LS, To CH.
            Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study.
            Ann Rheum Dis 2013; 72:659-64. doi: 10.1136/annrheumdis-2012-201393
            http://www.ncbi.nlm.nih.gov/pubmed/22589375
          • Jónsdóttir T, Zickert A, Sundelin B, Henriksson EW, van Vollenhoven RF, Gunnarsson I.
            Long-term follow-up in lupus nephritis patients treated with rituximab—clinical and histopathological response
            Rheumatology 2013 May; 52:847-55 doi:10.1093/rheumatology/kes348.
            http://rheumatology.oxfordjournals.org/content/52/5/847.abstract
 
MARZO 2013
          • Sozeri B, Deveci M, Dincel N, Mir S. Pediatr Nephrol.
            The early cardiovascular changes in pediatric patients with systemic lupus erythematosus. 
            Pediatr Nephrol. 2013 Mar;28(3):471-6. doi: 10.1007/s00467-012-2342-2. Epub 2012 Nov 8.
            http://www.ncbi.nlm.nih.gov/pubmed/23135607
          • Brunner HI, Klein-Gitelman MS, Zelko F, Thomas EC, Hummel J, Nelson SM, Huggins J, Curran ML, Roebuck-Spencer T, Beebe DW, Ying J.
            Validation of the Pediatric Automated Neuropsychological Assessment Metrics in childhood-onset systemic lupuserythematosus.
            Arthritis Care Res (Hoboken). 2013 Mar;65(3):372-81. doi: 10.1002/acr.21835.
            http://onlinelibrary.wiley.com/doi/10.1002/acr.21835/pdf
 
ENERO 2013
          • Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel K, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K,Martini A, Ruperto N, Lovell D, Brunner HI.
            Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus.
            Ann Rheum Dis. 2013 Jan 23. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23345596
          • Levy DM, Peschken CA, Tucker LB, Chédeville G, Huber AM, Pope JE and the Canadian Network for Improved Outcomes in SLE 1000 Faces Investigators and Silverman ED.
            Influence of ethnicity on childhood-onset systemic lupus erythematosus: Results from a multiethnic multicenter Canadian cohort.
            Arthritis Care Res 2013 Jan; 65 (1):152-60. DOI: 10.1002/acr.21779.
            http://onlinelibrary.wiley.com/doi/10.1002/acr.21779/abstract
 
DICIEMBRE 2012
          • Livingston B, Bonner A, Pope J
            Differences in autoantibody profiles and disease activity and damage scores between childhood- and adult-onset systemic lupus erythematosus: a meta-analysis.
            Semin Arthritis Rheum. 2012 Dec;42(3):271-80. doi: 10.1016/j.semarthrit.2012.05.001.
            http://www.ncbi.nlm.nih.gov/pubmed/22704358
 
NOVIEMBRE 2012
          • Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT.
            Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
            Ann Rheum Dis. 2012 Nov;71(11):1771-82. doi: 10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31.
 
AGOSTO 2012
          • Hiraki LT, Feldman CH, Liu J, Alarcón GS, Fischer MA, Winkelmayer WC, Costenbader KH.
            Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population.
            Arthritis Rheum 2012 Aug;64(8):2669-76. doi: 10.1002/art.34472.
            http://www.ncbi.nlm.nih.gov/pubmed/22847366
 
JULIO 2012

 

  • Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Archer N, Bailey K, Davidson J, Baildam EM, Cleary G, McCann LJ, Beresford 
    MW; UK Juvenile-Onset Systemic Lupus Erythematosus Study Group.
    Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
    Arthritis Rheum. 2012 Jul;64(7):2356-65. doi: 10.1002/art.34410.
    https://onlinelibrary.wiley.com/doi/10.1002/art.34410
PATROCINADORES